
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBADFF926575533DADFF00239E2D9E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cells">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954561/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cells">
<meta name="citation_title" content="Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response">
<meta name="citation_author" content="Rüdiger Braun">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Olha Lapshyna">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Jessica Watzelt">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Maren Drenckhan">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Axel Künstner">
<meta name="citation_author_institution" content="Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author_institution" content="Institute for Cardiogenetics, University of Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Benedikt Färber">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Ahmed Ahmed Mohammed Hael">
<meta name="citation_author_institution" content="First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany">
<meta name="citation_author" content="Louisa Bolm">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Kim Christin Honselmann">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Björn Konukiewitz">
<meta name="citation_author_institution" content="Institute of Pathology, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany">
<meta name="citation_author" content="Darko Castven">
<meta name="citation_author_institution" content="First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany">
<meta name="citation_author" content="Malte Spielmann">
<meta name="citation_author_institution" content="Institute of Human Genetics, University of Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Sivahari Prasad Gorantla">
<meta name="citation_author_institution" content="Department of Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Hauke Busch">
<meta name="citation_author_institution" content="Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author_institution" content="Institute for Cardiogenetics, University of Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Jens-Uwe Marquardt">
<meta name="citation_author_institution" content="First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany">
<meta name="citation_author" content="Tobias Keck">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Ulrich Friedrich Wellner">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author" content="Hendrik Ungefroren">
<meta name="citation_author_institution" content="Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany">
<meta name="citation_author_institution" content="First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany">
<meta name="citation_author_institution" content="Institute of Pathology, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany">
<meta name="citation_publication_date" content="2023 Feb 11">
<meta name="citation_volume" content="12">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="587">
<meta name="citation_doi" content="10.3390/cells12040587">
<meta name="citation_pmid" content="36831254">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954561/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954561/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954561/pdf/cells-12-00587.pdf">
<meta name="description" content="The prognosis of pancreatic ductal adenocarcinoma (PDAC) is exceedingly poor. Although surgical resection is the only curative treatment option, multimodal treatment is of the utmost importance, as only about 20% of tumors are primarily resectable ...">
<meta name="og:title" content="Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The prognosis of pancreatic ductal adenocarcinoma (PDAC) is exceedingly poor. Although surgical resection is the only curative treatment option, multimodal treatment is of the utmost importance, as only about 20% of tumors are primarily resectable ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954561/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9954561">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/cells12040587"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/cells-12-00587.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9954561%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9954561/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9954561/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954561/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cells.png" alt="Cells logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cells" title="Link to Cells" shape="default" href="http://www.mdpi.com/journal/cells" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cells</button></div>. 2023 Feb 11;12(4):587. doi: <a href="https://doi.org/10.3390/cells12040587" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/cells12040587</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Cells%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cells%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cells%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cells%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Braun%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Rüdiger Braun</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Rüdiger Braun</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Conceptualization, Formal analysis, Investigation, Writing – original draft, Project administration, Funding acquisition</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Braun%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rüdiger Braun</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lapshyna%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Olha Lapshyna</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Olha Lapshyna</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lapshyna%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Olha Lapshyna</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Watzelt%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Jessica Watzelt</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Jessica Watzelt</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Watzelt%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jessica Watzelt</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Drenckhan%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Maren Drenckhan</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Maren Drenckhan</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Drenckhan%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maren Drenckhan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22K%C3%BCnstner%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Axel Künstner</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Axel Künstner</span></h3>
<div class="p">
<sup>2</sup>Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, 23538 Lübeck, Germany</div>
<div class="p">
<sup>3</sup>Institute for Cardiogenetics, University of Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22K%C3%BCnstner%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Axel Künstner</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22F%C3%A4rber%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Benedikt Färber</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Benedikt Färber</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22F%C3%A4rber%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Benedikt Färber</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hael%20AAM%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Ahmed Ahmed Mohammed Hael</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Ahmed Ahmed Mohammed Hael</span></h3>
<div class="p">
<sup>4</sup>First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hael%20AAM%22%5BAuthor%5D" class="usa-link"><span class="name western">Ahmed Ahmed Mohammed Hael</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bolm%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Louisa Bolm</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Louisa Bolm</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bolm%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Louisa Bolm</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Honselmann%20KC%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Kim Christin Honselmann</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Kim Christin Honselmann</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Honselmann%20KC%22%5BAuthor%5D" class="usa-link"><span class="name western">Kim Christin Honselmann</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Konukiewitz%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Björn Konukiewitz</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Björn Konukiewitz</span></h3>
<div class="p">
<sup>5</sup>Institute of Pathology, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany</div>
<div>Resources</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Konukiewitz%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Björn Konukiewitz</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Castven%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Darko Castven</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Darko Castven</span></h3>
<div class="p">
<sup>4</sup>First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Castven%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Darko Castven</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spielmann%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Malte Spielmann</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Malte Spielmann</span></h3>
<div class="p">
<sup>6</sup>Institute of Human Genetics, University of Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spielmann%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Malte Spielmann</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gorantla%20SP%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Sivahari Prasad Gorantla</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Sivahari Prasad Gorantla</span></h3>
<div class="p">
<sup>7</sup>Department of Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gorantla%20SP%22%5BAuthor%5D" class="usa-link"><span class="name western">Sivahari Prasad Gorantla</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Busch%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Hauke Busch</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Hauke Busch</span></h3>
<div class="p">
<sup>2</sup>Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, 23538 Lübeck, Germany</div>
<div class="p">
<sup>3</sup>Institute for Cardiogenetics, University of Lübeck, 23538 Lübeck, Germany</div>
<div>Investigation, Resources</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Busch%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hauke Busch</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marquardt%20JU%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Jens-Uwe Marquardt</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Jens-Uwe Marquardt</span></h3>
<div class="p">
<sup>4</sup>First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany</div>
<div>Resources, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marquardt%20JU%22%5BAuthor%5D" class="usa-link"><span class="name western">Jens-Uwe Marquardt</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Keck%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Tobias Keck</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Tobias Keck</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Resources, Funding acquisition</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Keck%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tobias Keck</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wellner%20UF%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Ulrich Friedrich Wellner</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Ulrich Friedrich Wellner</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div>Resources, Writing – review &amp; editing, Funding acquisition</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wellner%20UF%22%5BAuthor%5D" class="usa-link"><span class="name western">Ulrich Friedrich Wellner</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ungefroren%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Hendrik Ungefroren</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Hendrik Ungefroren</span></h3>
<div class="p">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div class="p">
<sup>4</sup>First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany</div>
<div class="p">
<sup>5</sup>Institute of Pathology, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany</div>
<div>Conceptualization, Formal analysis, Investigation, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ungefroren%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hendrik Ungefroren</span></a>
</div>
</div>
<sup>1,</sup><sup>4,</sup><sup>5,</sup><sup>*</sup>
</div>
<div class="cg p">Editors: <span class="name western">Haoqiang Ying</span>, <span class="name western">Wantong Yao</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-cells-12-00587">
<sup>1</sup>Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div id="af2-cells-12-00587">
<sup>2</sup>Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, 23538 Lübeck, Germany</div>
<div id="af3-cells-12-00587">
<sup>3</sup>Institute for Cardiogenetics, University of Lübeck, 23538 Lübeck, Germany</div>
<div id="af4-cells-12-00587">
<sup>4</sup>First Medical Department, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany</div>
<div id="af5-cells-12-00587">
<sup>5</sup>Institute of Pathology, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany</div>
<div id="af6-cells-12-00587">
<sup>6</sup>Institute of Human Genetics, University of Lübeck, 23538 Lübeck, Germany</div>
<div id="af7-cells-12-00587">
<sup>7</sup>Department of Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany</div>
<div class="author-notes p"><div class="fn" id="c1-cells-12-00587">
<sup>*</sup><p class="display-inline">Correspondence: <span>ruediger.braun@uksh.de</span> (R.B.); <span>hendrik.ungeforen@uksh.de</span> (H.U.)</p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Rüdiger Braun</span></strong>: <span class="role">Conceptualization, Formal analysis, Investigation, Writing – original draft, Project administration, Funding acquisition</span>
</div>
<div>
<strong class="contrib"><span class="name western">Olha Lapshyna</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jessica Watzelt</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Axel Künstner</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Benedikt Färber</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ahmed Ahmed Mohammed Hael</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Louisa Bolm</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Kim Christin Honselmann</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Björn Konukiewitz</span></strong>: <span class="role">Resources</span>
</div>
<div>
<strong class="contrib"><span class="name western">Darko Castven</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Malte Spielmann</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Sivahari Prasad Gorantla</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Hauke Busch</span></strong>: <span class="role">Investigation, Resources</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jens-Uwe Marquardt</span></strong>: <span class="role">Resources, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Tobias Keck</span></strong>: <span class="role">Resources, Funding acquisition</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ulrich Friedrich Wellner</span></strong>: <span class="role">Resources, Writing – review &amp; editing, Funding acquisition</span>
</div>
<div>
<strong class="contrib"><span class="name western">Hendrik Ungefroren</span></strong>: <span class="role">Conceptualization, Formal analysis, Investigation, Writing – original draft</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Haoqiang Ying</span></strong>: <span class="role">Academic Editor</span>
</div>
<div>
<strong class="contrib"><span class="name western">Wantong Yao</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 Dec 2; Revised 2023 Feb 2; Accepted 2023 Feb 9; Collection date 2023 Feb.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2023 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9954561  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36831254/" class="usa-link">36831254</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The prognosis of pancreatic ductal adenocarcinoma (PDAC) is exceedingly poor. Although surgical resection is the only curative treatment option, multimodal treatment is of the utmost importance, as only about 20% of tumors are primarily resectable at the time of diagnosis. The choice of chemotherapeutic treatment regimens involving gemcitabine and FOLFIRINOX is currently solely based on the patient’s performance status, but, ideally, it should be based on the tumors’ individual biology. We established two novel patient-derived primary cell lines from surgical PDAC specimens. LuPanc-1 and LuPanc-2 were derived from a pT3, pN1, G2 and a pT3, pN2, G3 tumor, respectively, and the clinical follow-up was fully annotated. STR-genotyping revealed a unique profile for both cell lines. The population doubling time of LuPanc-2 was substantially longer than that of LuPanc-1 (84 vs. 44 h). Both cell lines exhibited a typical epithelial morphology and expressed moderate levels of CK7 and E-cadherin. LuPanc-1, but not LuPanc-2, co-expressed E-cadherin and vimentin at the single-cell level, suggesting a mixed epithelial-mesenchymal differentiation. LuPanc-1 had a missense mutation (p.R282W) and LuPanc-2 had a frameshift deletion (p.P89X) in <em>TP53</em>. <em>BRCA2</em> was nonsense-mutated (p.Q780*) and <em>CREBBP</em> was missense-mutated (p.P279R) in LuPanc-1. <em>CDKN2A</em> was missense-mutated (p.H83Y) in LuPanc-2. Notably, only LuPanc-2 harbored a partial or complete deletion of <em>DPC4</em>. LuPanc-1 cells exhibited high basal and transforming growth factor (TGF)-β1-induced migratory activity in real-time cell migration assays, while LuPanc-2 was refractory. Both LuPanc-1 and LuPanc-2 cells responded to treatment with TGF-β1 with the activation of SMAD2; however, only LuPanc-1 cells were able to induce TGF-β1 target genes, which is consistent with the absence of <em>DPC4</em> in LuPanc-2 cells. Both cell lines were able to form spheres in a semi-solid medium and in cell viability assays, LuPanc-1 cells were more sensitive than LuPanc-2 cells to treatment with gemcitabine and FOLFIRINOX. In summary, both patient-derived cell lines show distinct molecular phenotypes reflecting their individual tumor biology, with a unique clinical annotation of the respective patients. These preclinical ex vivo models can be further explored for potential new treatment strategies and might help in developing personalized (targeted) therapy regimens.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> pancreatic cancer, primary cell line, patient-derived cancer model, precision medicine</p></section></section><section id="sec1-cells-12-00587"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Pancreatic cancer is currently the fourth most common cause of cancer-related deaths and is predicted to be the second leading cause of cancer-related mortality by the year 2030 [<a href="#B1-cells-12-00587" class="usa-link" aria-describedby="B1-cells-12-00587">1</a>]. The majority of malignant neoplasms of the pancreas are ductal adenocarcinomas (PDAC) [<a href="#B2-cells-12-00587" class="usa-link" aria-describedby="B2-cells-12-00587">2</a>], and the prognosis of PDAC is exceedingly poor due to several reasons. Most PDACs are notably resistant to conventional (radio)chemotherapy.</p>
<p>Surgical resection is the only curative treatment option for pancreatic cancer. However, only 10–20% of patients present with resectable tumors at the time of diagnosis, 30–40% present with a borderline resectable tumor, and 50–60% present with metastatic disease [<a href="#B2-cells-12-00587" class="usa-link" aria-describedby="B2-cells-12-00587">2</a>]. There is growing evidence for a better oncological outcome for patients with borderline resectable tumors after neoadjuvant treatment [<a href="#B3-cells-12-00587" class="usa-link" aria-describedby="B3-cells-12-00587">3</a>,<a href="#B4-cells-12-00587" class="usa-link" aria-describedby="B4-cells-12-00587">4</a>]. A higher proportion of R0 resections can be achieved in patients with resectable and borderline resectable PDAC after neoadjuvant treatment [<a href="#B5-cells-12-00587" class="usa-link" aria-describedby="B5-cells-12-00587">5</a>].</p>
<p>The adjuvant treatment of patients with resectable PDAC by chemotherapy results in better overall survival. Modified combination therapy consisting of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (mFOLFIRINOX) resulted in a significantly better median overall survival of 54.4 months compared to that of gemcitabine alone (35.0 months) [<a href="#B6-cells-12-00587" class="usa-link" aria-describedby="B6-cells-12-00587">6</a>]. However, the progress in the treatment of patients with advanced-stage disease has been modest. Combination therapies such as mFOLFIRINOX or gemcitabine with albumin-bound (nab)-paclitaxel only result in marginal improvements in the overall survival in these patients [<a href="#B7-cells-12-00587" class="usa-link" aria-describedby="B7-cells-12-00587">7</a>,<a href="#B8-cells-12-00587" class="usa-link" aria-describedby="B8-cells-12-00587">8</a>].</p>
<p>Overall, the 5-year survival rate of PDAC patients remains as low as 5–8% [<a href="#B9-cells-12-00587" class="usa-link" aria-describedby="B9-cells-12-00587">9</a>]. The selection of mFOLFIRINOX or gemcitabine (with nab-paclitaxel) is currently based on the patient’s performance status and comorbidities, whereas the individual tumor biology is not considered. Multiple studies were aimed at establishing molecular profiles in PDACs [<a href="#B10-cells-12-00587" class="usa-link" aria-describedby="B10-cells-12-00587">10</a>,<a href="#B11-cells-12-00587" class="usa-link" aria-describedby="B11-cells-12-00587">11</a>,<a href="#B12-cells-12-00587" class="usa-link" aria-describedby="B12-cells-12-00587">12</a>]. As reviewed by Nevala-Plagemann et al., comprehensive genomic profiling might facilitate the identification of subsets of patients with actionable alterations who can potentially benefit from new targeted therapies [<a href="#B13-cells-12-00587" class="usa-link" aria-describedby="B13-cells-12-00587">13</a>]. For instance, genomic loss in the cancer cells of <em>CDKN2A</em> (encoding the cyclin-dependent kinase inhibitor p16<sup>INK4</sup>) and <em>DPC4</em>, encoding SMAD4, a central mediator of transforming growth factor (TGF)-β signaling, has been implicated in modifying the response to gemcitabine or 5-FU [<a href="#B14-cells-12-00587" class="usa-link" aria-describedby="B14-cells-12-00587">14</a>,<a href="#B15-cells-12-00587" class="usa-link" aria-describedby="B15-cells-12-00587">15</a>,<a href="#B16-cells-12-00587" class="usa-link" aria-describedby="B16-cells-12-00587">16</a>]. However, targeted therapies for PDAC patients have not become an integral part of clinical routine practice so far [<a href="#B17-cells-12-00587" class="usa-link" aria-describedby="B17-cells-12-00587">17</a>]. Taken together, there is an unmet clinical need (i) to identify biomarkers that are predictive of the response to treatment and allow for personalized therapy and (ii) to find alternative, targeted treatment options for patients who do not respond to treatment regimens that are currently used in clinical practice.</p>
<p>Preclinical models of PDAC are essential for drug development and the identification of predictive biomarkers. Primary, patient-derived cell lines are an indispensable tool among ex vivo models. Primary cell lines can provide valuable information on the phenotype and genotype of individual tumors, allow for functional assays of the individual tumor biology, and be used for the development of personalized treatment strategies by enabling individualized therapeutic drug testing ex vivo. However, the efficient ex vivo expansion of human carcinomas in tissue culture, especially that of PDAC, remains technically challenging. The Cancer Cell Line Encyclopedia (CCLE) from the Broad Institute comprises 60 pancreatic cell lines. Nevertheless, the full spectrum of the complex and diverse tumor biology of PDAC is not reflected sufficiently by these cell lines, and the clinical annotation and oncological outcome of the respective patient are mostly missing.</p>
<p>Here, we describe two newly established patient-derived cell lines from surgical PDAC specimens named LuPanc-1 and LuPanc-2. Both cell lines were comprehensively characterized and tested with respect to the standard therapy regimens gemcitabine and FOLFIRINOX.</p></section><section id="sec2-cells-12-00587"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="sec2dot1-cells-12-00587"><h3 class="pmc_sec_title">2.1. Tissue Collection, Cell Line Establishment, Fibroblast Depletion, and Generation of Single-Cell-Derived Clonal Cultures</h3>
<p>The tissue was collected directly after the surgical resection of the tumor after approval by the University of Lübeck’s local ethics committee (# 16-281). The tissue was processed within 1 h after surgical resection and cut into 3–5 mm pieces using a scalpel. Pieces were dissociated using collagenase I (1000 U/mL; Gibco, Waltham, MA, USA) for 120 min at 37 °C. The cells were plated on tissue culture dishes in DMEM GlutaMAX<sup>TM</sup> with 4.5 g/L glucose (Gibco) supplemented with 20% (<em>v</em>/<em>v</em>) fetal calf serum (FCS) and 100 μg/mL streptomycin/penicillin. The cells were cultured at 37 °C in a humidified incubator with 5% CO<sub>2</sub>. The cells began to form colonies after about 7 d. Subsequently, the medium was replaced every 3–4 d. The number of cocultured fibroblasts was periodically reduced by differential trypsinization. After reaching stable growth of the cultured tumor cells, fibroblasts were depleted by an immunomagnetic assay based on fibroblast-specific antigens (Anti-Fibroblast MicroBeads, human, Miltenyi Biotec, Bergisch Gladbach, Germany). Single-cell-derived clonal cultures were established from primary cultures by limited dilution, as previously described for the permanent PDAC cell line PANC-1 [<a href="#B18-cells-12-00587" class="usa-link" aria-describedby="B18-cells-12-00587">18</a>]. The cells were routinely checked for mycoplasma contamination by PCR (MycoScope PCR Detection Kit, Genlantis, San Diego, CA, USA). Cell line authentication was performed by short tandem repeat (STR) profiling using the PowerPlex<sup>®</sup> 21 System (Promega, Madison, WI, USA), according to the manufacturer’s instructions.</p></section><section id="sec2dot2-cells-12-00587"><h3 class="pmc_sec_title">2.2. Growth Curves</h3>
<p>Growth curves for both cell lines were established by counting cells in three independent experiments every 24 h for 7 and 10 d for LuPanc-1 and LuPanc-2, respectively, after seeding 80,000 cells per well in a six-well plate. The final cell count was carried out after harvesting the cells using Accumax (PAN Biotech) in an improved Neubauer hemocytometer. The total cell number was determined by averaging the cell count in eight 1 mm squares. The cell numbers were normalized to the cell number initially counted 24 h after seeding.</p></section><section id="sec2dot3-cells-12-00587"><h3 class="pmc_sec_title">2.3. Chemotherapy and Measurement of Cell Survival</h3>
<p>To measure the sensitivity to chemotherapy, 6000 cells of LuPanc-1 and 8000 cells of LuPanc-2 growing in a log phase were seeded per well in 96-well plates, and chemotherapeutics were added 24 h after cell seeding. For gemcitabine treatment, gemcitabine (Sigma Aldrich, St. Louis, MO, USA) was added to a final concentration in a range of 2.5–320 nmol/L for LuPanc-1 and 10–12,800 nmol/L for LuPanc-2. For FOLFIRINOX treatment, 5-FU, irinotecan, leucovorin, and oxaliplatin were combined, and the final concentration ranged as follows: 5-FU (Medac) 0.005–426 µmol/L, irinotecan (Medac) 0.07 nmol/L–5.78 µmol/L, oxaliplatin (GRY) 0.062 nmol/L–4.96 µmol/L, and leucovorin (Sigma Aldrich) 0.078 nmol/L–6.19 µmol/L. After 72 h, cell metabolism was measured by a Resazurin reduction assay. Resazurin (STEMCELL) was diluted in DPBS to a concentration of 10 mg/mL. This stock solution was further diluted in the medium, 20 µL was added per well to a final concentration of 40 µg/mL, and the cells were incubated for 2 h at 37 °C in a humidified incubator with 5% CO<sub>2</sub>. Extinction was quantified with a plate photometer, according to the manufacturer’s instructions. The excitation wavelength was set to 545 nm, and the emission wavelength was set to 600 nm. Each experiment was performed in triplicate and repeated three times.</p></section><section id="sec2dot4-cells-12-00587"><h3 class="pmc_sec_title">2.4. Immunofluorescence</h3>
<p>The cells were cultivated for 72 h, with subsequent fixation with 4% paraformaldehyde in chamber slides (Falcon<sup>®</sup> Culture Slides; Corning, NY, USA and Sarstedt, Nümbrecht, Germany). The cells were permeabilized with 0.1% Triton-X and sequentially treated with goat serum, primary monoclonal mouse anti-human CK 7 antibody (DAKO Corporation, Clone OV-TL 12/30, 1:200 dilution), primary monoclonal rabbit anti-human E-cadherin antibody (Cell Signaling Technology, Frankfurt/Main, Germany, #3195, 1:200 dilution), primary monoclonal mouse anti-human vimentin antibody (Abcam, Cambridge, UK, V1-RE/1, ab3974,1:200 dilution), anti-Mouse Alexa Fluor<sup>®</sup> 594 secondary antibody (Abcam, #150116, 1:500 dilution), and anti-Rabbit Alexa Fluor<sup>®</sup> 488 secondary antibody (Abcam, #150077, 1:500 dilution). Appropriate negative controls were performed. Coverslips were mounted with Fluoromount-G medium including DAPI (Southern Biotech, Huntsville, AL, USA). The cells were visualized using a BZ-9000 (BIOREVO) fluorescent microscope (Keyence, Osaka, Japan) with a 20× PlanFluor EL NA 0.45 Ph1 objective lens under 0.285 s of exposure time for CK7 and 0.2 s of exposure time for E-cadherin and vimentin.</p></section><section id="sec2dot5-cells-12-00587"><h3 class="pmc_sec_title">2.5. Immunoblotting</h3>
<p>The Western blot procedure was performed as described in detail earlier [<a href="#B19-cells-12-00587" class="usa-link" aria-describedby="B19-cells-12-00587">19</a>]. Briefly, equal amounts of crude proteinaceous extracts from each cell line (three preparations harvested at different times during the continuous culture) were fractionated by SDS-PAGE on mini-PROTEAN TGX any-kD precast gels or TGX Stain-Free FastCast gels (BioRad, Munich, Germany) and blotted to PVDF membranes. The membranes were blocked with nonfat dry milk or bovine serum albumin and incubated with primary antibodies to E-cadherin (#610181, BD Transduction Laboratories, Heidelberg, Germany) or vimentin (clone V9, #V6630, Sigma-Aldrich, Steinheim, Germany), phospho-Smad2 (S465/S467) (#3101, Cell Signaling Technology, Frankfurt/Main, Germany), Smad2 (#1736-1, Epitomics, Burlingame, CA, USA), and GAPDH (Cell Signaling Technology) as loading controls.</p></section><section id="sec2dot6-cells-12-00587"><h3 class="pmc_sec_title">2.6. Soft Agar/Matrigel-Based Sphere-Forming Assays</h3>
<p>To determine the sphere-forming potential of Lü-PANC cells, Soft Agar- and Basement Membrane Extract (BME)-based assays were employed. For the Soft Agar-based assay, a total of 1000 viable single-cells were resuspended in 0.25% agar (Carl Roth, Karlsruhe, Germany) and added on top of the precoated 48-well plate with 1.3% agar containing DMEM with 20% FBS. For the sphere formation assay in BME, 1000 cells were resuspended in 50 µL DMEM with 20% FBS, mixed with 150 µL Cultrex (Bio-Techne, Minneapolis, MN, USA), and then plated on 48-well plates. During spheroid cultivation, the medium was replaced every 3 d. Sphere formation in both assays was monitored for 14 d. All experiments were performed in two independent biological replicates with three technical replicates each.</p></section><section id="sec2dot7-cells-12-00587"><h3 class="pmc_sec_title">2.7. Migration Assays</h3>
<p>The migratory/invasive activities of LuPanc-1 and LuPanc-2 were determined with xCELLigence<sup>®</sup> technology (ACEA Biosciences, San Diego, supplied by OLS, Bremen, Germany), as outlined in detail in previous publications [<a href="#B19-cells-12-00587" class="usa-link" aria-describedby="B19-cells-12-00587">19</a>,<a href="#B20-cells-12-00587" class="usa-link" aria-describedby="B20-cells-12-00587">20</a>]. The lower side of the CIM plate-16 porous membrane was coated with a 1:1 mixture (<em>v</em>/<em>v</em>) of collagen I and collagen IV (30 μL) to facilitate the adherence of the cells and thus enhance the duration of the signal recording. Each well was loaded with 60,000 (LuPanc-1) or 80,000 (LuPanc-2) cells in standard growth medium (see above). Cells were allowed to settle in the laminar flow hood for 30 min at RT, after which the assay was started and run for 24 or 48 h. Some assays were performed in the absence or presence of recombinant human (rh) TGF-β1 (RELIATech GmbH, Wolfenbüttel, Germany) or the TGF-β type I receptor/ALK5 serine/threonine kinase inhibitor SB431542 (Merck, Darmstadt, Germany). Data acquisition (with signal recording every 15 min) and analysis were performed with the RTCA software (version 1.2, ACEA Biosciences).</p></section><section id="sec2dot8-cells-12-00587"><h3 class="pmc_sec_title">2.8. Whole Exome and Sanger Sequencing</h3>
<p>DNA was extracted from both cell lines using the AllPrep DNA/RNA/Protein Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer’s instructions. Targets were enriched using the Agilent SureSelectXT kit, and libraries were prepared using the NEB Next Ultra DNA Library Prep Kit. Sequencing was performed on a NovaSeq 6000 using the v1.5 chemistry.</p>
<p>Sequencing data (paired-end fastq files) were trimmed (adapter and quality values) using <span class="font-variant-small-caps">fastp</span> [<a href="#B21-cells-12-00587" class="usa-link" aria-describedby="B21-cells-12-00587">21</a>] (v0.23.0; minimum length, 50 bp; maximum unqualified bases, 30%; trim tail set to 1), and filtered reads were mapped against GRCh38 using bwa mem [<a href="#B22-cells-12-00587" class="usa-link" aria-describedby="B22-cells-12-00587">22</a>] (v0.7.15). Mappings were converted to BAM format using <span class="font-variant-small-caps">Picard Tools</span> (v2.18.4), and postprocessing was performed following GATK’s [<a href="#B23-cells-12-00587" class="usa-link" aria-describedby="B23-cells-12-00587">23</a>] best practices. Briefly, mate-pair information was fixed, PCR duplicates were removed, and base quality recalibration was performed using Picard Tools, GATK (v4.2.4.1), and dbSNP v138 [<a href="#B24-cells-12-00587" class="usa-link" aria-describedby="B24-cells-12-00587">24</a>]. Single-nucleotide variants (SNVs) and short insertions and deletions (indels) were identified following Mutect2 (GATK) in the tumor-only mode, with gnomAD as a germline resource and the b38 exome panel from the 1000-genome project as a panel of normals. Variants were filtered and annotated using <span class="font-variant-small-caps">Variant Effect Predictor</span> (VEP v103, GRCh38; adding CADD v1.6, dbNSFP v4.1a10, and GNOMAD r3.0 as additional annotations), and annotations were converted into MAF format using <span class="font-variant-small-caps">vcf2maf</span> (V1.6.21) (<a href="http://doi.org/10.5281/ZENODO.593251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://doi.org/10.5281/ZENODO.593251</a> (accessed on 24 April 2022); coverage for each variant was extracted directly from the vcf INFO field. The top 20 frequently mutated genes (FLAGS) [<a href="#B25-cells-12-00587" class="usa-link" aria-describedby="B25-cells-12-00587">25</a>] and MUC genes were removed from further analysis, and the remaining somatic variants were filtered as follows: minimum coverage of 40, minimum variant allele frequency of 10%, and only variants with a frequency &lt; 0.1% in 1000 genomes, gnomAD, or ExAC were considered for subsequent downstream analysis.</p>
<p>Copy number aberrations were detected using Control-FREEC (v11.4) [<a href="#B26-cells-12-00587" class="usa-link" aria-describedby="B26-cells-12-00587">26</a>], and sequencing coverage was estimated using <span class="font-variant-small-caps">mosdepth</span> (v0.3.2) [<a href="#B27-cells-12-00587" class="usa-link" aria-describedby="B27-cells-12-00587">27</a>], resulting in 122x coverage for LuPanc1 (±93x) and 115x coverage for LuPanc-2 (±86x).</p>
<p>For the Sanger sequencing of the KRAS locus, the following primers were used (5′–3′): forward: CCTTATGTGTGACATGTTCT; reverse: ATGGTCCTGCACCAGTAATA (amplicon size: 218 bp). Sanger sequencing was carried out as described previously [<a href="#B28-cells-12-00587" class="usa-link" aria-describedby="B28-cells-12-00587">28</a>].</p></section><section id="sec2dot9-cells-12-00587"><h3 class="pmc_sec_title">2.9. Quantitative RT-PCR Analysis (qPCR)</h3>
<p>The total RNA was isolated from LuPanc-1 and LuPanc-2 cells with an RNAeasy kit (Qiagen, Hilden, Germany). A total of 2.5 μg of RNA of each sample was reverse transcribed (1 h, 37 °C) with 200 U of M-MLV Reverse Transcriptase and 2.5 μM random hexamers. Target gene expression was quantified by qPCR on an I-Cycler (BioRad, Munich, Germany) with Maxima SYBR Green Mastermix (Thermo Fisher Scientific, Waltham, MA, USA) and normalized to the expression of either TATA box-binding protein (TBP) or GAPDH. The PCR primer sequences for <em>DPC4</em>, <em>SMAD2</em>, <em>SERPINE1</em>, <em>SNAI2</em>, <em>SOX2, TBP</em> and <em>GAPDH</em> are given in <a href="#app1-cells-12-00587" class="usa-link">Table S1</a>.</p></section></section><section id="sec3-cells-12-00587"><h2 class="pmc_sec_title">3. Results</h2>
<section id="sec3dot1-cells-12-00587"><h3 class="pmc_sec_title">3.1. Patient History and the Establishment of Patient-Derived Cell Lines</h3>
<p>We established two patient-derived primary pancreatic cancer cell lines from PDACs (LuPanc-1 and LuPanc-2). LuPanc-1 cells were derived from a PDAC of a 64-year-old male patient who presented to our surgical department with a locally advanced tumor of the pancreatic tail with infiltration of the stomach. The patient underwent distal pancreatectomy, splenectomy, and simultaneous partial resection of the stomach. The histopathological assessment of the resected tumor revealed a moderately differentiated ductal adenocarcinoma of the pancreas (TNM classification: pT3,N1,L1,V1,Pn1,R0,G2). The patient received adjuvant chemotherapy with a reduced dose of FOLFIRINOX due to intolerance. The patient developed a local recurrence and peritoneal carcinomatosis 9 months after the surgical resection of the primary tumor and subsequently received palliative chemotherapy with gemcitabine/nab-paclitaxel.</p>
<p>LuPanc-2 cells were derived from a locally advanced PDAC of a 63-year-old female patient. The patient presented with a tumor located in the pancreatic corpus with local infiltration of the portal vein and celiac trunk. The patient underwent an extended multiorgan pancreatic corpus and tail resection (Appleby procedure) at our department. The histopathological assessment of the resected tumor revealed a poorly differentiated ductal adenocarcinoma of the pancreas (TNM classification: pT3,N2,L1,V1,Pn1,R0,G3). The patient received adjuvant chemotherapy with FOLFIRINOX but developed a retrogastric local recurrence 8 months after the resection of the primary tumor. The patient subsequently received palliative radiotherapy.</p>
<p>For both cell lines, cells were isolated immediately after the surgical resection of the tumor by mechanical and enzymatic dissociation of a representative specimen. After 7 days of cultivation, first, adherent colonies of epithelial tumor cells surrounded by fibroblasts appeared, as shown exemplarily for LuPanc-1 in <a href="#cells-12-00587-f001" class="usa-link">Figure 1</a>A. The number of cocultured fibroblasts was periodically reduced by differential trypsinization (<a href="#cells-12-00587-f001" class="usa-link">Figure 1</a>B). After reaching the stable growth of the cultured tumor cells, the fibroblasts were depleted by an immunomagnetic assay (<a href="#cells-12-00587-f001" class="usa-link">Figure 1</a>C). Both patient-derived PDAC cell lines showed a typical epithelial morphology. LuPanc-1 cells were small and grew in dense, large colonies, whereas LuPanc-2 cells were comparatively large and grew in small islets (<a href="#cells-12-00587-f001" class="usa-link">Figure 1</a>D,E). Both cell lines expressed moderate levels of cytokeratin 7 (CK7), as determined by immunofluorescent staining (<a href="#cells-12-00587-f001" class="usa-link">Figure 1</a>F–K).</p>
<figure class="fig xbox font-sm" id="cells-12-00587-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9954561_cells-12-00587-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/9954561/32620f8746bc/cells-12-00587-g001.jpg" loading="lazy" height="1019" width="763" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/cells-12-00587-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Morphology and immunofluorescent staining for CK7 in the patient-derived cell lines, LuPanc-1 and LuPanc-2. (<strong>A</strong>) LuPanc-1 cells 7 d after cell isolation. (<strong>B</strong>) LuPanc-1 cells after 30 d in culture and partial depletion of fibroblasts. (<strong>C</strong>) LuPanc-1 cells after total fibroblast depletion. (<strong>D</strong>) LuPanc-1 and (<strong>E</strong>) LuPanc-2 cells without fibroblasts. (<strong>F</strong>–<strong>K</strong>) Immunofluorescent staining of LuPanc-1 (<strong>F</strong>–<strong>H</strong>) and LuPanc-2 (<strong>I</strong>–<strong>K</strong>) cells for CK7 (<strong>F</strong>,<strong>I</strong>), DAPI (<strong>G</strong>,<strong>J</strong>), and overlay of CK7 and DAPI (<strong>H</strong>,<strong>K</strong>).</p></figcaption></figure></section><section id="sec3dot2-cells-12-00587"><h3 class="pmc_sec_title">3.2. Authentication of LuPanc-1 and LuPanc-2</h3>
<p>Both established cell lines were authenticated by STR genotyping for 21 loci (<a href="#cells-12-00587-t001" class="usa-link">Table 1</a>). No identical STR profiles were found in the DSMZ STR database, indicating that both cell lines are novel [<a href="#B29-cells-12-00587" class="usa-link" aria-describedby="B29-cells-12-00587">29</a>]. We did not detect multiple peaks in the examined loci, which excludes cross-contamination by other cell lines. Contamination with mycoplasma was excluded using a PCR-based assay (data not shown).</p>
<section class="tw xbox font-sm" id="cells-12-00587-t001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Short tandem repeat analysis.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Locus</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LuPanc-1</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LuPanc-2</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D3S1358</td>
<td align="center" valign="middle" rowspan="1" colspan="1">16/17</td>
<td align="center" valign="middle" rowspan="1" colspan="1">15,17</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D1S1656</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11/14</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12,15</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D6S1043</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12/17</td>
<td align="center" valign="middle" rowspan="1" colspan="1">19</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D13S317</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11/12</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11/12</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Penta E</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7/12</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D16S539</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11/13</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12,13</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D18S51</td>
<td align="center" valign="middle" rowspan="1" colspan="1">16</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D2S1338</td>
<td align="center" valign="middle" rowspan="1" colspan="1">22/23</td>
<td align="center" valign="middle" rowspan="1" colspan="1">17/23</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">SCF1PO</td>
<td align="center" valign="middle" rowspan="1" colspan="1">10/12</td>
<td align="center" valign="middle" rowspan="1" colspan="1">10/11</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Penta D</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13/15</td>
<td align="center" valign="middle" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">TH01</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7/9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6/9</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">vWA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">17/20</td>
<td align="center" valign="middle" rowspan="1" colspan="1">14/19</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D21S11</td>
<td align="center" valign="middle" rowspan="1" colspan="1">30</td>
<td align="center" valign="middle" rowspan="1" colspan="1">27/30</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D7S820</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11</td>
<td align="center" valign="middle" rowspan="1" colspan="1">8/10</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D5S818</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11/13</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">TPOX</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12</td>
<td align="center" valign="middle" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D8S1179</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12/13</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13/15</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D12S391</td>
<td align="center" valign="middle" rowspan="1" colspan="1">21/23</td>
<td align="center" valign="middle" rowspan="1" colspan="1">17/19</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">D19S433</td>
<td align="center" valign="middle" rowspan="1" colspan="1">14/15</td>
<td align="center" valign="middle" rowspan="1" colspan="1">15</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">FGA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">22/24</td>
<td align="center" valign="middle" rowspan="1" colspan="1">20/21.2</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AM</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">X/Y</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">X</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cells-12-00587-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec3dot3-cells-12-00587"><h3 class="pmc_sec_title">3.3. Growth Kinetics and Epithelial-Mesenchymal Phenotyping</h3>
<p>First, we determined the general growth behavior of both cell lines. The population doubling times of LuPanc-1 and LuPanc-2 cells were estimated to be 44 h and 84 h, respectively, as measured by manual cell counting, indicating that LuPanc-2 cells grew substantially slower than LuPanc-1 cells (<a href="#cells-12-00587-f002" class="usa-link">Figure 2</a>A). To further asses cellular growth, general metabolic activity was measured based on the Resazurin reduction assay. In line with the cell counting results, the metabolic activity was substantially lower in LuPanc-2 cells compared to that in LuPanc-1 cells. With increasing cell density, however, metabolic activities became more similar in both cell lines (<a href="#app1-cells-12-00587" class="usa-link">Figure S1</a>).</p>
<figure class="fig xbox font-sm" id="cells-12-00587-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9954561_cells-12-00587-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/9954561/34734207c604/cells-12-00587-g002.jpg" loading="lazy" height="1080" width="761" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/cells-12-00587-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Molecular characterization of the LuPanc-1 and LuPanc-2 cell lines. (<strong>A</strong>) Growth curves for LuPanc-1 and LuPanc-2. (<strong>B</strong>) Crude proteinaceous extracts were prepared from both cell lines and subjected to the immunoblot analysis of E-cadherin and vimentin. (<strong>C</strong>) As the control, E-cadherin and vimentin expression in LuPanc-1 cells is shown in comparison to that in other PDAC-derived tumor cell lines of either the quasimesenchymal (PANC-1, MIA PaCa-2) or epithelial (CAPAN-1, COLO 357) subtype [<a href="#B31-cells-12-00587" class="usa-link" aria-describedby="B31-cells-12-00587">31</a>]. The detection of GAPDH was used in (<strong>B</strong>) and (<strong>C</strong>) to verify equal loading. (<strong>D</strong>–<strong>G</strong>) Double immunofluorescence staining of E-cadherin (<strong>D</strong>) and vimentin (<strong>E</strong>) in small clusters of LuPanc-1 cells. Nuclei were counterstained with DAPI (<strong>F</strong>), and concurrent expression was visualized by overlay (<strong>G</strong>).</p></figcaption></figure><p>The aggressiveness of pancreatic cancer cells is associated with the acquisition of mesenchymal characteristics in comparison to those cells that are well-differentiated and epithelial-like [<a href="#B30-cells-12-00587" class="usa-link" aria-describedby="B30-cells-12-00587">30</a>]. Thus, we determined for both cell lines whether the cells are more epithelial or mesenchymal-like by measuring the protein levels of E-cadherin and vimentin by Western Blotting. Interestingly, LuPanc-1 cells expressed both E-cadherin and vimentin, while LuPanc-2 cells presented with similar levels of E-cadherin but lacked detectable levels of vimentin (<a href="#cells-12-00587-f002" class="usa-link">Figure 2</a>B). In separate immunoblots, LuPanc-1 cells were then compared to several permanent cell lines representing either the quasimesenchymal subtype—with a high expression of vimentin but only low (PANC-1) or undetectable (MIA PaCa-2) levels of -E-cadherin—or the epithelial subtype with strong E-cadherin but no vimentin expression (CAPAN-1 and COLO 357). From the data in <a href="#cells-12-00587-f002" class="usa-link">Figure 2</a>C, it became clear that LuPanc-1 cells cannot be attributed to one of these extreme phenotypes. Rather, they display a mixed phenotype combining both epithelial and mesenchymal traits. To reveal whether this is due to two different populations of cells, of which one expresses E-cadherin and the other expresses vimentin, or, alternatively, to the co-expression of both markers by the same individual cell, we performed double immunofluorescent staining of the E-cadherin and vimentin of LuPanc-1 cells. Interestingly, these stains show that individual LuPanc-1 cells indeed co-express both proteins but also appear to differ in their ratio of E-cadherin and vimentin expression (<a href="#cells-12-00587-f002" class="usa-link">Figure 2</a>D–G). To confirm this latter observation, we additionally generated single-cell-derived clonal cell lines from the parental LuPanc-1 culture by limited dilution. The immunoblot analysis of E-cadherin and vimentin expression in these clonal cultures mirrored the results from the immunofluorescence analyses. Specifically, all six single-cell-derived clones co-expressed both proteins, albeit with substantial quantitative differences, which were stronger for vimentin than for E-cadherin (<a href="#app1-cells-12-00587" class="usa-link">Figure S2</a>). The ratios of E-cadherin to vimentin were similar among the clones, except for clone 6F9, which displayed very strong vimentin expression and, hence, a low E-cadherin:vimentin ratio (<a href="#app1-cells-12-00587" class="usa-link">Figure S2</a>). Together, these data confirm vimentin expression by the tumor cells rather than by residual contaminating fibroblasts and suggest that LuPanc-1 cells undergo spontaneous EMT.</p></section><section id="sec3dot4-cells-12-00587"><h3 class="pmc_sec_title">3.4. Genomic Landscape</h3>
<p>We profiled the genomic landscape of both cell lines by whole-exome sequencing (WES). After the removal of commonly mutated genes without any effect, 135 and 76 mutations were detected in LuPanc-1 and LuPanc-2, respectively. Most of the mutations were missense mutations in both cell lines, followed by nonsense mutations (<a href="#cells-12-00587-t002" class="usa-link">Table 2</a>). Mutations in oncogenes and tumor suppressor genes, according to Vogelstein and coworkers [<a href="#B32-cells-12-00587" class="usa-link" aria-describedby="B32-cells-12-00587">32</a>], were detected as follows: <em>TP53</em> had a missense mutation in LuPanc-1 (p.R282W) and a frameshift deletion (p.P89X) in LuPanc-2 (<a href="#cells-12-00587-f003" class="usa-link">Figure 3</a>A). <em>BRCA2</em> was nonsense-mutated (p.Q780*) in LuPanc-1. <em>CDKN2A</em> (encoding p16<sup>INK4</sup>) had a missense mutation (p.H83Y) in LuPanc-2 and <em>CREBBP</em> had a missense mutation (p.P279R) in LuPanc-1. We further specifically analyzed <em>KRAS</em>, <em>DPC4</em>, <em>RNF43</em>, <em>ARID1A</em>, <em>TGFBR2</em>, <em>GNAS</em>, <em>RREB1</em>, and <em>PBRM1</em>, which have been described to be recurrently mutated in PDAC by the Cancer Genome Atlas Research Network [<a href="#B33-cells-12-00587" class="usa-link" aria-describedby="B33-cells-12-00587">33</a>], but none of these genes were found to be mutated by WES. However, when analyzing the copy number variations (CNV) of these genes, we detected losses of <em>KRAS</em>, <em>BRCA2</em>, <em>CDKN2A</em>, and <em>DPC4</em> as well as gains of <em>RNF43</em>, <em>GNAS,</em> and <em>PBRM1</em> in both cell lines. For <em>ARID1A</em>, we detected a loss in LuPanc-1 but a gain in LuPanc-2. Notably, a complete loss of <em>DPC4</em> (absence of exons 1–5, as confirmed by sequencing) and a loss of <em>RREB1</em> were found in LuPanc-2 but not LuPanc-1 cells, while, conversely, LuPanc-1 but not LuPanc-2 cells showed a loss of <em>TP53</em> and a gain of <em>CREBBP</em>. <a href="#cells-12-00587-f003" class="usa-link">Figure 3</a>B summarizes all mutations detected in both cell lines as a complete oncoplot. As we did not detect sufficient coverage for the <em>KRAS</em> codons 12 and 13 in the WES data, we specifically analyzed these loci by subsequent Sanger sequencing and detected a codon 12 mutation (Gly-Val) in both cell lines.</p>
<section class="tw xbox font-sm" id="cells-12-00587-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Total number of mutations after processing.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Frame Shift Deletion</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Frame Shift Insertion</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">In-Frame Deletion</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Missense Mutation</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nonsense Mutation</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Splice Site</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">LuPanc-1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">124</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">135</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LuPanc-2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cells-12-00587-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="cells-12-00587-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9954561_cells-12-00587-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/9954561/d6bfed88746a/cells-12-00587-g003.jpg" loading="lazy" height="392" width="716" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/cells-12-00587-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mutational landscape of LuPanc-1 and LuPanc-2 cells based on WES. (<strong>A</strong>) Mutations in common oncogenes and tumor suppressor genes detected in both cell lines, according to Vogelstein and colleagues [<a href="#B32-cells-12-00587" class="usa-link" aria-describedby="B32-cells-12-00587">32</a>]. (<strong>B</strong>) Complete oncoplot of all mutations detected in both cell lines. For an enlargement of this oncoplot, see <a href="#app1-cells-12-00587" class="usa-link">Figure S3</a>.</p></figcaption></figure></section><section id="sec3dot5-cells-12-00587"><h3 class="pmc_sec_title">3.5. Sphere-Forming Capacity in Semi-Solid Medium</h3>
<p>The mutational signatures and, in particular, the presence of mutant KRAS suggested that both cell lines possess a transformed phenotype. To scrutinize this functionally, we performed sphere formation assays, exploiting the ability of cancer cells to grow and generate visible colonies (spheres) from single-cells when cultured in a semi-solid medium. As expected, both cell lines generated large numbers of spheres in soft agar and Matrigel, with LuPanc-2 cells forming substantially more spheres than LuPanc-1 cells (<a href="#cells-12-00587-f004" class="usa-link">Figure 4</a>).</p>
<figure class="fig xbox font-sm" id="cells-12-00587-f004"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9954561_cells-12-00587-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/9954561/183f0ec24985/cells-12-00587-g004.jpg" loading="lazy" height="400" width="686" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/cells-12-00587-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Tumor sphere assay of LuPanc-1 and LuPanc-2 cells. Both cell lines formed spheres in cultrex and soft agar. LuPanc-2 cells formed significantly more spheres compared to LuPanc-1 cells under both conditions. Data are the mean ± SD of two biological replicates, each comprising three technical triplicates. The asterisks (*) indicate a significant difference (<em>p</em> &lt; 0.05, Student’s <em>t</em> test).</p></figcaption></figure></section><section id="sec3dot6-cells-12-00587"><h3 class="pmc_sec_title">3.6. Characterization of TGF-β Signaling</h3>
<p>Signaling by TGF-β plays antagonistic roles during carcinogenesis by initially inhibiting epithelial growth and later promoting the progression of advanced tumors, i.e., by stimulating migration/invasion, thus having a dual role as a tumor suppressor and promoter. Genes that define components of this pathway, such as <em>DPC4</em> (encoding SMAD4) and <em>TGFBR2</em> (encoding the type II receptor), have been described to be recurrently mutated in PDAC and to be associated with increased or decreased resistance to gemcitabine [<a href="#B14-cells-12-00587" class="usa-link" aria-describedby="B14-cells-12-00587">14</a>,<a href="#B15-cells-12-00587" class="usa-link" aria-describedby="B15-cells-12-00587">15</a>,<a href="#B16-cells-12-00587" class="usa-link" aria-describedby="B16-cells-12-00587">16</a>]. Moreover, inhibitors of the ALK5 kinase augmented the cytotoxicity of gemcitabine in both parental and gemcitabine-resistant pancreatic cancer cells [<a href="#B34-cells-12-00587" class="usa-link" aria-describedby="B34-cells-12-00587">34</a>], and Galunisertib, the first-in-class, first-in-human, oral small-molecule ALK5 inhibitor that enters clinical development in combination with gemcitabine, improved overall survival vs. gemcitabine alone in patients with unresectable pancreatic cancer [<a href="#B35-cells-12-00587" class="usa-link" aria-describedby="B35-cells-12-00587">35</a>]. In view of the gemcitabine viability assays shown below (see <a href="#sec3dot7-cells-12-00587" class="usa-link">Section 3.7</a>), it was of interest to evaluate the cells’ sensitivity to treatment with TGF-β. Towards this end, we treated cultures of LuPanc-1 and LuPanc-2 cells with rhTGF-β1 for 2 h. This induced C-terminal phosphorylation (reflecting activation) of the receptor-regulated Smad protein, SMAD2 (<a href="#cells-12-00587-f005" class="usa-link">Figure 5</a>A), suggesting the presence of functional TGF-β receptor signaling in both cell lines. To evaluate if signals transmit to the nucleus to result in corresponding changes in gene expression, we monitored several known TGF-β target genes for their response to rhTGF-β1. We found that both short-term (24 or 48 h) and long-term (15 d) stimulation of LuPanc-1 cells, but not LuPanc-2 cells, resulted in the upregulation of <em>SERPINE1</em> (encoding plasminogen activator-inhibitor type 1, PAI-1), <em>SNAI2</em> (encoding SNAIL2/SLUG), or <em>SOX2</em>, respectively (<a href="#cells-12-00587-f005" class="usa-link">Figure 5</a>B). In search of a molecular explanation for the unresponsiveness of LuPanc-2 cells to rhTGF-β1 stimulation with respect to changes in target gene expression, we recalled that, in WES analysis, <em>DPC4</em> was found to be lost in LuPanc-2 but not LuPanc-1 cells (<a href="#cells-12-00587-f003" class="usa-link">Figure 3</a>B). The absence of SMAD4 mRNA in LuPanc-2 cells was then confirmed by qPCR, while the levels in LuPanc1 were comparable to those in PANC-1 cells (<a href="#cells-12-00587-f005" class="usa-link">Figure 5</a>C) known to harbor wild-type <em>DPC4</em> and to be TGF-β-sensitive [<a href="#B19-cells-12-00587" class="usa-link" aria-describedby="B19-cells-12-00587">19</a>,<a href="#B20-cells-12-00587" class="usa-link" aria-describedby="B20-cells-12-00587">20</a>]. However, the abundance of mRNA for SMAD2 was equal in all three lines (<a href="#cells-12-00587-f005" class="usa-link">Figure 5</a>C), which is consistent with the presence of the SMAD2 protein (<a href="#cells-12-00587-f005" class="usa-link">Figure 5</a>A). From these data, it can be concluded that the failure of LuPanc-2 cells to respond to treatment with rhTGF-β1 is due to the absence of the common mediator Smad, SMAD4.</p>
<figure class="fig xbox font-sm" id="cells-12-00587-f005"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9954561_cells-12-00587-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/9954561/f7c9730c664b/cells-12-00587-g005.jpg" loading="lazy" height="446" width="748" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/cells-12-00587-f005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Characterization of TGF-β signaling in LuPanc-1 and LuPanc-2 cells. (<strong>A</strong>) Phospho-immunoblotting of SMAD2 in LuPanc-1, LuPanc-2, and PANC-1 cells as the control. Cells were treated with rhTGF-β1 for 2 h and subjected to sequential immunoblotting of phospho-SMAD2 (p-SMAD2), (total) SMAD2, and GAPDH to control for equal loading. (<strong>B</strong>) Monitoring of TGF-β target genes for their response to treatment with rhTGF-β1. LuPanc-1 and LuPanc-2 cells were stimulated short-term (48 h) for PAI-1 and SLUG or long-term (15 d) for SOX2 with rhTGF-β1 (5 ng/mL) and subjected to qPCR for <em>SERPINE1</em>, <em>SNAI2</em>, or <em>SOX2</em>, respectively. The asterisks (∗) indicate a significant difference; ∗ <em>p</em> &lt; 0.05, ∗∗∗ <em>p</em> &lt; 0.001. (<strong>C</strong>) Detection of SMAD4 mRNA levels by qPCR in LuPanc-1 and LuPanc-2 cells relative to those in PANC-1 cells set arbitrarily at 1.0. SMAD2 mRNA was detected in the same samples as a positive control.</p></figcaption></figure></section><section id="sec3dot7-cells-12-00587"><h3 class="pmc_sec_title">3.7. Migratory Capacity</h3>
<p>We next evaluated the migratory capacity of LuPanc-1 and LuPanc-2 cells using the xCELLigence RTCA technology (OLS, Bremen, Germany), which represents a non-invasive and label-free approach for the continuous (real-time) monitoring of cell migration and invasion on a cell culture level [<a href="#B36-cells-12-00587" class="usa-link" aria-describedby="B36-cells-12-00587">36</a>]. For LuPanc-1 cells, high migratory activity was recorded, while that of LuPanc-2 cells was close to background levels (<a href="#cells-12-00587-f006" class="usa-link">Figure 6</a>A).</p>
<figure class="fig xbox font-sm" id="cells-12-00587-f006"><h4 class="obj_head">Figure 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9954561_cells-12-00587-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/9954561/f5827955b8bd/cells-12-00587-g006.jpg" loading="lazy" height="186" width="728" alt="Figure 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/cells-12-00587-f006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Measurement of basal and TGF-β-induced migratory capacity of LuPanc-1 and LuPanc-2 cells. (<strong>A</strong>) Both cell lines (green curve/tracing A: LuPanc-1, red curve/tracing B: LuPanc-2) were subjected to a real-time cell migration assay on an xCELLigence platform for 24 h. The relative migratory activity is plotted on the ordinate and given as the dimensionless Cell Index. Data are the mean ± SD of quadruplicate wells. The assay shown is representative of three assays performed in total. (<strong>B</strong>) The same procedure as that in (<strong>A</strong>), except that LuPanc-1 cells were assayed in the absence (green curve/tracing A) or presence (blue curve/tracing B) of rhTGF-β1 (5 ng/mL) for 48 h. In another four wells, cells were treated with rhTGF-β1 plus the ALK5 serine/threonine kinase inhibitor SB431542 (5 µM, red curve/tracing C). Data shown are the mean ± SD of quadruplicate wells from one out of two assays. The asterisk (∗) marks the time point at which the difference between TGF-β1-treated and untreated control cells was first statistically significant. Differences remained as such until the end of the assay. No significant differences were noted between the untreated control and the rhTGF-β1 + SB431542-treated cells.</p></figcaption></figure><p>Having shown above that LuPanc-1 cells have retained sensitivity to rhTGF-β1 with respect to the activation of Smad proteins and invasion-associated target genes, we sought to know whether rhTGF-β1 would also impact the cells’ migratory behavior in vitro. To this end, this growth factor increased the migratory activity over that of control cells (blue curve/tracing B vs. green curve/tracing A, <a href="#cells-12-00587-f006" class="usa-link">Figure 6</a>B). Notably, the TGF-β type I receptor/ALK5 serine/threonine kinase inhibitor SB431542 was able to relieve this stimulatory effect (red curve/tracing C, <a href="#cells-12-00587-f006" class="usa-link">Figure 6</a>B), indicating that the TGF-β1 effect on migratory activity was specific and receptor-mediated. As expected, LuPanc-2 cells failed to respond to TGF-β1 stimulation with (enhanced) migratory activity under the same conditions (data not shown).</p></section><section id="sec3dot8-cells-12-00587"><h3 class="pmc_sec_title">3.8. Treatment Response to Gemcitabine and FOLFIRINOX</h3>
<p>As described above, gemcitabine and FOLFIRINOX are essential chemotherapeutics used in clinical routine practice for PDAC treatment. Accordingly, the sensitivity of both cell lines was tested in Resazurin-based viability assays for gemcitabine monotherapy and FOLFIRINOX by determining the respective half-maximal inhibition concentration (IC<sub>50</sub>). The IC<sub>50</sub> for gemcitabine was 13.6 nM (IC<sub>90</sub> of 50.5 nM) for LuPanc-1 and 357.1 nM for LuPanc-2 (IC<sub>90</sub> of 2812 nM) (<a href="#cells-12-00587-f007" class="usa-link">Figure 7</a>, left-hand graph). The different levels of resistance of LuPanc-1 and LuPanc-2 cells to gemcitabine were verified by FACS analyses in independent experiments (<a href="#app1-cells-12-00587" class="usa-link">Figure S4</a>). The IC<sub>50</sub> value for FOLFIRINOX (as a concentration of 5-FU in FOLFIRINOX) was 573.8 nM (IC<sub>90</sub> of 5659 nM) for LuPanc-1 (<a href="#cells-12-00587-f007" class="usa-link">Figure 7</a>, right-hand graph). For LuPanc-2 cells, it was not possible to determine the IC<sub>50</sub> (or IC<sub>90</sub>) for FOLFIRINOX since we were unable to obtain a normal dose–response curve.</p>
<figure class="fig xbox font-sm" id="cells-12-00587-f007"><h4 class="obj_head">Figure 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9954561_cells-12-00587-g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b265/9954561/a322bdf58018/cells-12-00587-g007.jpg" loading="lazy" height="253" width="755" alt="Figure 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/cells-12-00587-f007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Evaluation of the proliferative response of LuPanc-1 and LuPanc-2 cells to gemcitabine or FOLFIRINOX. Both cell lines were treated with either gemcitabine (<strong>A</strong>) or FOLFIRINOX (<strong>B</strong>), followed by the addition of Resazurin and OD measurement.</p></figcaption></figure></section></section><section id="sec4-cells-12-00587"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>PDAC is a highly malignant carcinoma with an exceedingly poor prognosis. The overall 5-year survival rate of PDAC patients is as low as 5–8% [<a href="#B9-cells-12-00587" class="usa-link" aria-describedby="B9-cells-12-00587">9</a>]. Surgical resection of the tumor is the only curative treatment option, and patients usually receive adjuvant chemotherapy after surgery [<a href="#B37-cells-12-00587" class="usa-link" aria-describedby="B37-cells-12-00587">37</a>,<a href="#B38-cells-12-00587" class="usa-link" aria-describedby="B38-cells-12-00587">38</a>]. However, about 60% of the patients already progressed to metastatic disease at the time of diagnosis [<a href="#B39-cells-12-00587" class="usa-link" aria-describedby="B39-cells-12-00587">39</a>]. For these patients, palliative chemotherapy is the only treatment option. In both cases, patients are commonly treated using either mFOLFIRINOX or gemcitabine (with nab-paclitaxel), according to current clinical guidelines. The tumor biology of individual patients is not considered for the selection of the chemotherapeutic treatment regimen. Targeted therapies are currently not an integral part of the clinical treatment in PDAC patients [<a href="#B40-cells-12-00587" class="usa-link" aria-describedby="B40-cells-12-00587">40</a>].</p>
<p>Preclinical studies using patient-derived cell lines may be useful in predicting the response of a particular patient to gemcitabine/FOLFIRINOX or for the development of alternative and novel treatment strategies. Several studies have described specific molecular subtypes of PDAC based on transcriptional profiles [<a href="#B10-cells-12-00587" class="usa-link" aria-describedby="B10-cells-12-00587">10</a>,<a href="#B11-cells-12-00587" class="usa-link" aria-describedby="B11-cells-12-00587">11</a>,<a href="#B12-cells-12-00587" class="usa-link" aria-describedby="B12-cells-12-00587">12</a>]. The quasi-mesenchymal subtype by Collisson et al. [<a href="#B10-cells-12-00587" class="usa-link" aria-describedby="B10-cells-12-00587">10</a>], the basal subtype by Moffitt et al. [<a href="#B11-cells-12-00587" class="usa-link" aria-describedby="B11-cells-12-00587">11</a>] and the squamous subtype by Bailey et al. [<a href="#B12-cells-12-00587" class="usa-link" aria-describedby="B12-cells-12-00587">12</a>] significantly overlap and have a worse clinical outcome when compared to other subtypes [<a href="#B41-cells-12-00587" class="usa-link" aria-describedby="B41-cells-12-00587">41</a>,<a href="#B42-cells-12-00587" class="usa-link" aria-describedby="B42-cells-12-00587">42</a>]. The Cancer Cell Line Encyclopedia (CCLE) from the Broad Institute comprises 60 pancreatic cell lines derived from primary tumors or metastasis. However, these cell lines do not fully reflect the diverse and complex tumor biology of PDACs and clinical annotation; especially, the oncological outcome of the respective patient is mostly missing. The correlation of findings on primary ex vivo cultures with the clinical outcome of the individual patients is crucial in the era of personalized precision medicine.</p>
<p>In this study, we established two novel PDAC-derived cell lines named LuPanc-1 and LuPanc-2 from the surgical specimens of PDAC patients. Both cell lines presented with a transformed phenotype, as evidenced by their mutational spectra and their ability to form spheres in semi-solid media, also suggesting that the cells have stem cell properties. Clinical follow-up was annotated for both patients, and both corresponding cell lines were characterized comprehensively at the molecular level and functionally with respect to invasive behavior and the response to chemotherapeutic drugs.</p>
<p>Primary, patient-derived cell cultures are a highly relevant tool because they reflect the in vivo state and physiology better compared to immortalized secondary cell lines. Both cell lines established in this study were taken into the primary culture directly from surgical specimens. They can be maintained in the culture without changes in cell dynamics and a loss of viability, obviating the need for cell immortalization [<a href="#B43-cells-12-00587" class="usa-link" aria-describedby="B43-cells-12-00587">43</a>,<a href="#B44-cells-12-00587" class="usa-link" aria-describedby="B44-cells-12-00587">44</a>]. Most available cell lines have been cultured and used as workhorses for experimental cancer research for decades, while LuPanc-1 and LuPanc-2 are two low-passage cell lines. The clonal dynamics of cell cultures that have been passaged in various laboratories over extensive periods of time need to be considered during experimental design and data evaluation and, in some cases, may complicate data interpretation and comparability. We therefore presume that our novel cell lines are a highly valuable tool, in addition to the commonly used cell lines. Another unique feature is their full clinical annotation; most of the commercially available cell lines lack any clinical information. Combining the information of the cells’ biology with the clinical course of the patients might help in better understanding or even predicting treatment responses.</p>
<p>Finally, one of the main drawbacks in the design of personalized treatment strategies is the marked inter-tumor heterogeneity in PDAC. As mentioned above, although the CCLE database already contains 60 pancreatic cancer cell lines, these include histological entities other than PDAC, and those within the PDAC fraction are likely to not represent the full spectrum of PDAC histomorphological subtypes. Moreover, a substantial number of those cell lines have been derived from metastases rather than the primary tumor, which means that these do not necessarily respond in the same way to chemotherapeutic drugs as the cancer cells from the patient’s primary tumor. With respect to histomorphological differentiation, LuPanc-1 cells present with a mixed phenotype co-expressing both epithelial and mesenchymal markers at a single-cell level, as demonstrated for E-cadherin and vimentin by the immunofluoresecence and immunoblot analysis of single-cell-derived clonal cultures. This phenotype has so far only been described for the PANC-1 cell line and has been shown to reflect the presence of subpopulations of cells with different EMT phenotypes [<a href="#B18-cells-12-00587" class="usa-link" aria-describedby="B18-cells-12-00587">18</a>]. This mixed phenotype of LuPanc-1 cells is indicative of cells that have undergone hybrid or partial EMT. Notably, these cells have been shown to be more plastic and to exhibit higher tumorigenic and stemness potential, eventually resulting in enhanced metastasis and therapy resistance [<a href="#B45-cells-12-00587" class="usa-link" aria-describedby="B45-cells-12-00587">45</a>]. Therefore, LuPanc-1 cells might be particularly useful when analyzing these properties, as previously shown for PANC-1 cells [<a href="#B31-cells-12-00587" class="usa-link" aria-describedby="B31-cells-12-00587">31</a>,<a href="#B46-cells-12-00587" class="usa-link" aria-describedby="B46-cells-12-00587">46</a>,<a href="#B47-cells-12-00587" class="usa-link" aria-describedby="B47-cells-12-00587">47</a>,<a href="#B48-cells-12-00587" class="usa-link" aria-describedby="B48-cells-12-00587">48</a>].</p>
<p>We also determined the response of both cell lines to gemcitabine and FOLFIRINOX, which are the relevant treatment regimens in current clinical care. LuPanc-2 was substantially more resistant to gemcitabine (IC<sub>50</sub> 357.1 nM) compared to LuPanc-1 (IC<sub>50</sub> 13.6 nM). LuPanc-1 showed a similar response to gemcitabine compared to other commonly used cell lines such as CAPAN-1 (11.5 nM), BxPC-3 (18 nM), MIA PaCa-2 (36–40 nM), and PANC-1 (50 nM) [<a href="#B49-cells-12-00587" class="usa-link" aria-describedby="B49-cells-12-00587">49</a>,<a href="#B50-cells-12-00587" class="usa-link" aria-describedby="B50-cells-12-00587">50</a>,<a href="#B51-cells-12-00587" class="usa-link" aria-describedby="B51-cells-12-00587">51</a>,<a href="#B52-cells-12-00587" class="usa-link" aria-describedby="B52-cells-12-00587">52</a>]. The response of LuPanc-1 to FOLFIRINOX was in line with those of other cell lines published recently by Begg et al. [<a href="#B53-cells-12-00587" class="usa-link" aria-describedby="B53-cells-12-00587">53</a>]. Surprisingly, we were not able to obtain a typical dose response for the slowly growing LuPanc-2 line under treatment for FOLFIRINOX, which most likely reflects the high level of resistance. In line with the poorer histopathological differentiation of LuPanc-2 in comparison to that of LuPanc-1, LuPanc-2 showed a worse response to gemcitabine and FOLFIRINOX.</p>
<p>Both patients who gave rise to our cell lines received additive therapy with FOLFIRINOX after surgery but developed a local recurrence in a short postoperative interval of 9 and 8 months, respectively. The patient from whom LuPanc-1 was derived received gemcitabine treatment for the local recurrence, which is in line with a good response of the derived cell line in vitro. However, the detected <em>BRCA2</em> nonsense mutation might offer a rationale for an alternative treatment strategy based on PARP inhibitors such as olaparib.</p>
<p>The epithelial-mesenchymal phenotyping of both cell lines showed that while the phenotype of LuPanc-2 cells was tentatively epithelial based on the presence of CK7 and E-cadherin, along with the absence of vimentin protein expression, LuPanc-1 cells combined both epithelial and mesenchymal traits, revealing a mixed E/M phenotype. Cells that co-express markers of both subtypes have been postulated to possess a higher stem cell potential and cellular plasticity. Tumor cells with this mixed phenotype, which is also referred to as partial or hybrid EMT, have been shown to be more metastatic [<a href="#B54-cells-12-00587" class="usa-link" aria-describedby="B54-cells-12-00587">54</a>], which is consistent with the high migratory activity of LuPanc-1 cells in real-time cell migration assays (<a href="#cells-12-00587-f006" class="usa-link">Figure 6</a>). For instance, we have recently shown that PANC-1 cells, which also co-express epithelial and mesenchymal markers, have a high propensity for transdifferentiation into specialized cell types such as insulin-expressing cells in vitro [<a href="#B47-cells-12-00587" class="usa-link" aria-describedby="B47-cells-12-00587">47</a>], and they are highly invasive in vitro and in vivo [<a href="#B19-cells-12-00587" class="usa-link" aria-describedby="B19-cells-12-00587">19</a>,<a href="#B20-cells-12-00587" class="usa-link" aria-describedby="B20-cells-12-00587">20</a>]. It will therefore be exciting to reveal whether LuPanc-1 cells, too, are more prone to ductal-to-endocrine differentiation and if they exhibit greater metastatic activity in vivo in mouse models of PDAC.</p>
<p>Of particular interest was the finding of the deletion of <em>DPC4</em> in LuPanc-2 cells by CNV analysis, which was subsequently confirmed by SMAD4-specific qPCR. <em>DPC4</em> has been described to be recurrently mutated in PDAC, and its genomic deletion was significantly correlated positively with disease progression [<a href="#B55-cells-12-00587" class="usa-link" aria-describedby="B55-cells-12-00587">55</a>] and negatively with progression-free survival [<a href="#B56-cells-12-00587" class="usa-link" aria-describedby="B56-cells-12-00587">56</a>]. In addition, the loss of <em>DPC4</em> was associated with an altered sensitivity to treatment with gemcitabine [<a href="#B14-cells-12-00587" class="usa-link" aria-describedby="B14-cells-12-00587">14</a>,<a href="#B15-cells-12-00587" class="usa-link" aria-describedby="B15-cells-12-00587">15</a>,<a href="#B57-cells-12-00587" class="usa-link" aria-describedby="B57-cells-12-00587">57</a>]. A previous study using a genetically defined pancreatic cancer cell panel, which tested the cancer cells’ responses to chemotherapeutic drugs, found that SMAD4-inactivated cancer cell lines were more sensitive to cisplatin and irinotecan by two- to fourfold, but they were only modestly less sensitive to gemcitabine [<a href="#B58-cells-12-00587" class="usa-link" aria-describedby="B58-cells-12-00587">58</a>]. Despite the lack of a correlation between the <em>DPC4</em> status and the gemcitabine response in this panel of PDAC cell lines, among <em>DPC4</em> isogenic cell lines, <em>DPC4</em>-defective cells were about twofold less sensitive to gemcitabine than wildtype cells. A correlation analysis for IC<sub>50</sub> values and TGF-β pathway activities in these isogenic cells confirmed a negative correlation with TGF-β pathway activities [<a href="#B58-cells-12-00587" class="usa-link" aria-describedby="B58-cells-12-00587">58</a>], matching the results from our study, in which a lack of TGF-β1 target gene responses correlated with a high gemcitabine IC<sub>50</sub> in LuPanc-2 cells. However, it should be mentioned that, in another study, both SMAD4-deleted PDAC cell lines and patient-derived organoids exhibited a <em>higher</em> sensitivity toward gemcitabine (and other cell cycle-targeting agents) due to the upregulation of cell cycle-related genes [<a href="#B16-cells-12-00587" class="usa-link" aria-describedby="B16-cells-12-00587">16</a>], suggesting that—unlike in LuPanc-2—SMAD4 deletion may also result in the activation of mitosis. Moreover, pancreatic cancer cells with p16<sup>INK4</sup> inactivation were three- to fourfold less sensitive to gemcitabine [<a href="#B58-cells-12-00587" class="usa-link" aria-describedby="B58-cells-12-00587">58</a>]. Since LuPanc-2 harbors a missense mutation (in addition to a loss) in <em>CDKN2A</em>, we speculate that the combined alterations in <em>CDKN2A</em> and <em>DPC4</em> are causal for the high gemcitabine IC<sub>50</sub> of LuPanc-2 cells. Another interesting issue is whether the inability of LuPanc-2 cells to exhibit basal migratory activity in vitro is a direct consequence of their unresponsiveness to TGF-β1 or the SMAD4 loss, i.e., due to the failure of autocrine TGF-β to stimulate cell motility.</p>
<p>Cell lines and, in particular, primary patient-derived cell lines are an essential tool for preclinical drug stratification and can help in developing personalized treatment regimens [<a href="#B59-cells-12-00587" class="usa-link" aria-describedby="B59-cells-12-00587">59</a>,<a href="#B60-cells-12-00587" class="usa-link" aria-describedby="B60-cells-12-00587">60</a>]. However, a limitation of cell line models is the lack of a specific tumor microenvironment, which not only mechanically compromises drug delivery but also possesses immune and drug-scavenging activity [<a href="#B61-cells-12-00587" class="usa-link" aria-describedby="B61-cells-12-00587">61</a>,<a href="#B62-cells-12-00587" class="usa-link" aria-describedby="B62-cells-12-00587">62</a>,<a href="#B63-cells-12-00587" class="usa-link" aria-describedby="B63-cells-12-00587">63</a>]. When using our novel cell lines for preclinical drug testing, this limitation needs to be considered and possibly addressed using complementary techniques.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We are indebted to Heike Albrecht for the excellent technical assistance. A.K. and H.B. acknowledge the computational support from the OMICS compute cluster at the University of Lübeck. We thank Darawalee Wangsa Zong for the linguistic revision of the manuscript.</p></section><section id="app1-cells-12-00587" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following supporting information can be downloaded at: <a href="https://www.mdpi.com/article/10.3390/cells12040587/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/article/10.3390/cells12040587/s1</a>, Figure S1: Cellular growth of LuPanc-1 and LuPanc-2, as measured by the Resazurin reduction assay. Figure S2: Immunoblot analysis of E-cadherin and vimentin in single-cell-derived clonal cultures of LuPanc-1 cells. Figure S3: Enlargement of the oncoplot in <a href="#cells-12-00587-f003" class="usa-link">Figure 3</a>B. Figure S4: Measurement of apoptosis induction in LuPanc-1 and LuPanc-2 cells under gemcitabine treatment by FACS analysis.; Table S1: Primer sequences used for qPCR.</p>
<section class="sm xbox font-sm" id="cells-12-00587-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/9954561/bin/cells-12-00587-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (1.7MB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, R.B. and H.U.; formal analysis, R.B. and H.U.; investigation, R.B., O.L., J.W., M.D., A.K., B.F., L.B., A.A.M.H., K.C.H., D.C., M.S., S.P.G., H.B. and H.U.; resources, B.K., H.B., J.-U.M., T.K., and U.F.W.; writing—original draft preparation, R.B. and H.U.; writing—review and editing, J.-U.M. and U.F.W.; project administration, R.B.; funding acquisition, R.B., T.K., and U.F.W. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of the University of Lübeck (# 16-281).</p></section><section id="notes3"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Informed consent was obtained from all subjects involved in the study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>All data reported are contained in the “Results” section and the <a href="#app1-cells-12-00587" class="usa-link">supplementary material</a>.</p></section><section id="notes5"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported in part by grants from the German Research Foundation (DFG) through the Clinician Scientist School Lübeck (DFG #413535489), the Junior Funding Program of the University of Lübeck, and the Brigitte and Dr. Konstanze Wegener Foundation (project # 81).</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Disclaimer/Publisher’s Note:</strong> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-cells-12-00587">
<span class="label">1.</span><cite>Rahib L., Smith B.D., Aizenberg R., Rosenzweig A.B., Fleshman J.M., Matrisian L.M. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. doi: 10.1158/0008-5472.CAN-14-0155.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-14-0155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24840647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Projecting%20cancer%20incidence%20and%20deaths%20to%202030:%20The%20unexpected%20burden%20of%20thyroid,%20liver,%20and%20pancreas%20cancers%20in%20the%20United%20States&amp;author=L.%20Rahib&amp;author=B.D.%20Smith&amp;author=R.%20Aizenberg&amp;author=A.B.%20Rosenzweig&amp;author=J.M.%20Fleshman&amp;volume=74&amp;publication_year=2014&amp;pages=2913-2921&amp;pmid=24840647&amp;doi=10.1158/0008-5472.CAN-14-0155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-cells-12-00587">
<span class="label">2.</span><cite>Kleeff J., Korc M., Apte M., La Vecchia C., Johnson C.D., Biankin A.V., Neale R.E., Tempero M., Tuveson D.A., Hruban R.H., et al.  Pancreatic cancer. Nat. Rev. Dis. Prim. 2016;2:16022. doi: 10.1038/nrdp.2016.22.</cite> [<a href="https://doi.org/10.1038/nrdp.2016.22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27158978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Dis.%20Prim.&amp;title=Pancreatic%20cancer&amp;author=J.%20Kleeff&amp;author=M.%20Korc&amp;author=M.%20Apte&amp;author=C.%20La%20Vecchia&amp;author=C.D.%20Johnson&amp;volume=2&amp;publication_year=2016&amp;pages=16022&amp;pmid=27158978&amp;doi=10.1038/nrdp.2016.22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-cells-12-00587">
<span class="label">3.</span><cite>Jang J.Y., Han Y., Lee H., Kim S.W., Kwon W., Lee K.H., Oh D.Y., Chie E.K., Lee J.M., Heo J.S., et al.  Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial. Ann. Surg. 2018;268:215–222. doi: 10.1097/SLA.0000000000002705.</cite> [<a href="https://doi.org/10.1097/SLA.0000000000002705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29462005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Surg.&amp;title=Oncological%20Benefits%20of%20Neoadjuvant%20Chemoradiation%20With%20Gemcitabine%20Versus%20Upfront%20Surgery%20in%20Patients%20With%20Borderline%20Resectable%20Pancreatic%20Cancer:%20A%20Prospective,%20Randomized,%20Open-label,%20Multicenter%20Phase%202/3%20Trial&amp;author=J.Y.%20Jang&amp;author=Y.%20Han&amp;author=H.%20Lee&amp;author=S.W.%20Kim&amp;author=W.%20Kwon&amp;volume=268&amp;publication_year=2018&amp;pages=215-222&amp;pmid=29462005&amp;doi=10.1097/SLA.0000000000002705&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-cells-12-00587">
<span class="label">4.</span><cite>Janssen Q.P., Buettner S., Suker M., Beumer B.R., Addeo P., Bachellier P., Bahary N., Bekaii-Saab T., Bali M.A., Besselink M.G., et al.  Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. J. Natl. Cancer Inst. 2019;111:782–794. doi: 10.1093/jnci/djz073.</cite> [<a href="https://doi.org/10.1093/jnci/djz073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6695305/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31086963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Neoadjuvant%20FOLFIRINOX%20in%20Patients%20With%20Borderline%20Resectable%20Pancreatic%20Cancer:%20A%20Systematic%20Review%20and%20Patient-Level%20Meta-Analysis&amp;author=Q.P.%20Janssen&amp;author=S.%20Buettner&amp;author=M.%20Suker&amp;author=B.R.%20Beumer&amp;author=P.%20Addeo&amp;volume=111&amp;publication_year=2019&amp;pages=782-794&amp;pmid=31086963&amp;doi=10.1093/jnci/djz073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-cells-12-00587">
<span class="label">5.</span><cite>Janssen Q.P., O’Reilly E.M., van Eijck C.H.J., Groot Koerkamp B. Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer. Front. Oncol. 2020;10:41. doi: 10.3389/fonc.2020.00041.</cite> [<a href="https://doi.org/10.3389/fonc.2020.00041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7005204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32083002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Oncol.&amp;title=Neoadjuvant%20Treatment%20in%20Patients%20With%20Resectable%20and%20Borderline%20Resectable%20Pancreatic%20Cancer&amp;author=Q.P.%20Janssen&amp;author=E.M.%20O%E2%80%99Reilly&amp;author=C.H.J.%20van%20Eijck&amp;author=B.%20Groot%20Koerkamp&amp;volume=10&amp;publication_year=2020&amp;pages=41&amp;pmid=32083002&amp;doi=10.3389/fonc.2020.00041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-cells-12-00587">
<span class="label">6.</span><cite>Conroy T., Hammel P., Hebbar M., Ben Abdelghani M., Wei A.C., Raoul J.L., Chone L., Francois E., Artru P., Biagi J.J., et al.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N. Engl. J. Med. 2018;379:2395–2406. doi: 10.1056/NEJMoa1809775.</cite> [<a href="https://doi.org/10.1056/NEJMoa1809775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30575490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=FOLFIRINOX%20or%20Gemcitabine%20as%20Adjuvant%20Therapy%20for%20Pancreatic%20Cancer&amp;author=T.%20Conroy&amp;author=P.%20Hammel&amp;author=M.%20Hebbar&amp;author=M.%20Ben%20Abdelghani&amp;author=A.C.%20Wei&amp;volume=379&amp;publication_year=2018&amp;pages=2395-2406&amp;pmid=30575490&amp;doi=10.1056/NEJMoa1809775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-cells-12-00587">
<span class="label">7.</span><cite>Conroy T., Desseigne F., Ychou M., Bouche O., Guimbaud R., Becouarn Y., Adenis A., Raoul J.L., Gourgou-Bourgade S., de la Fouchardiere C., et al.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 2011;364:1817–1825. doi: 10.1056/NEJMoa1011923.</cite> [<a href="https://doi.org/10.1056/NEJMoa1011923" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21561347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=FOLFIRINOX%20versus%20gemcitabine%20for%20metastatic%20pancreatic%20cancer&amp;author=T.%20Conroy&amp;author=F.%20Desseigne&amp;author=M.%20Ychou&amp;author=O.%20Bouche&amp;author=R.%20Guimbaud&amp;volume=364&amp;publication_year=2011&amp;pages=1817-1825&amp;pmid=21561347&amp;doi=10.1056/NEJMoa1011923&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-cells-12-00587">
<span class="label">8.</span><cite>Von Hoff D.D., Ervin T., Arena F.P., Chiorean E.G., Infante J., Moore M., Seay T., Tjulandin S.A., Ma W.W., Saleh M.N., et al.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 2013;369:1691–1703. doi: 10.1056/NEJMoa1304369.</cite> [<a href="https://doi.org/10.1056/NEJMoa1304369" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4631139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24131140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Increased%20survival%20in%20pancreatic%20cancer%20with%20nab-paclitaxel%20plus%20gemcitabine&amp;author=D.D.%20Von%20Hoff&amp;author=T.%20Ervin&amp;author=F.P.%20Arena&amp;author=E.G.%20Chiorean&amp;author=J.%20Infante&amp;volume=369&amp;publication_year=2013&amp;pages=1691-1703&amp;pmid=24131140&amp;doi=10.1056/NEJMoa1304369&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-cells-12-00587">
<span class="label">9.</span><cite>Heinemann V., Schmidberger H. Duktales Adenokarzinom des Pankreas. Der. Onkol. 2019;25:642–644. doi: 10.1007/s00761-019-0603-4.</cite> [<a href="https://doi.org/10.1007/s00761-019-0603-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Der.%20Onkol.&amp;title=Duktales%20Adenokarzinom%20des%20Pankreas&amp;author=V.%20Heinemann&amp;author=H.%20Schmidberger&amp;volume=25&amp;publication_year=2019&amp;pages=642-644&amp;doi=10.1007/s00761-019-0603-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-cells-12-00587">
<span class="label">10.</span><cite>Collisson E.A., Sadanandam A., Olson P., Gibb W.J., Truitt M., Gu S., Cooc J., Weinkle J., Kim G.E., Jakkula L., et al.  Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 2011;17:500–503. doi: 10.1038/nm.2344.</cite> [<a href="https://doi.org/10.1038/nm.2344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3755490/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21460848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=Subtypes%20of%20pancreatic%20ductal%20adenocarcinoma%20and%20their%20differing%20responses%20to%20therapy&amp;author=E.A.%20Collisson&amp;author=A.%20Sadanandam&amp;author=P.%20Olson&amp;author=W.J.%20Gibb&amp;author=M.%20Truitt&amp;volume=17&amp;publication_year=2011&amp;pages=500-503&amp;pmid=21460848&amp;doi=10.1038/nm.2344&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-cells-12-00587">
<span class="label">11.</span><cite>Moffitt R.A., Marayati R., Flate E.L., Volmar K.E., Loeza S.G., Hoadley K.A., Rashid N.U., Williams L.A., Eaton S.C., Chung A.H., et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 2015;47:1168–1178. doi: 10.1038/ng.3398.</cite> [<a href="https://doi.org/10.1038/ng.3398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4912058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26343385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Genet.&amp;title=Virtual%20microdissection%20identifies%20distinct%20tumor-%20and%20stroma-specific%20subtypes%20of%20pancreatic%20ductal%20adenocarcinoma&amp;author=R.A.%20Moffitt&amp;author=R.%20Marayati&amp;author=E.L.%20Flate&amp;author=K.E.%20Volmar&amp;author=S.G.%20Loeza&amp;volume=47&amp;publication_year=2015&amp;pages=1168-1178&amp;pmid=26343385&amp;doi=10.1038/ng.3398&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-cells-12-00587">
<span class="label">12.</span><cite>Bailey P., Chang D.K., Nones K., Johns A.L., Patch A.M., Gingras M.C., Miller D.K., Christ A.N., Bruxner T.J., Quinn M.C., et al.  Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47–52. doi: 10.1038/nature16965.</cite> [<a href="https://doi.org/10.1038/nature16965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26909576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genomic%20analyses%20identify%20molecular%20subtypes%20of%20pancreatic%20cancer&amp;author=P.%20Bailey&amp;author=D.K.%20Chang&amp;author=K.%20Nones&amp;author=A.L.%20Johns&amp;author=A.M.%20Patch&amp;volume=531&amp;publication_year=2016&amp;pages=47-52&amp;pmid=26909576&amp;doi=10.1038/nature16965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-cells-12-00587">
<span class="label">13.</span><cite>Nevala-Plagemann C., Hidalgo M., Garrido-Laguna I. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nat. Rev. Clin. Oncol. 2020;17:108–123. doi: 10.1038/s41571-019-0281-6.</cite> [<a href="https://doi.org/10.1038/s41571-019-0281-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31705130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;title=From%20state-of-the-art%20treatments%20to%20novel%20therapies%20for%20advanced-stage%20pancreatic%20cancer&amp;author=C.%20Nevala-Plagemann&amp;author=M.%20Hidalgo&amp;author=I.%20Garrido-Laguna&amp;volume=17&amp;publication_year=2020&amp;pages=108-123&amp;pmid=31705130&amp;doi=10.1038/s41571-019-0281-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-cells-12-00587">
<span class="label">14.</span><cite>Melisi D., Xia Q., Paradiso G., Ling J., Moccia T., Carbone C., Budillon A., Abbruzzese J.L., Chiao P.J. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. J.. Natl.. Cancer Inst.. 2011;103:1190–1204. doi: 10.1093/jnci/djr243.</cite> [<a href="https://doi.org/10.1093/jnci/djr243" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3149044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21743023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J..%20Natl..%20Cancer%20Inst..&amp;title=Modulation%20of%20pancreatic%20cancer%20chemoresistance%20by%20inhibition%20of%20TAK1&amp;author=D.%20Melisi&amp;author=Q.%20Xia&amp;author=G.%20Paradiso&amp;author=J.%20Ling&amp;author=T.%20Moccia&amp;volume=103&amp;publication_year=2011&amp;pages=1190-1204&amp;pmid=21743023&amp;doi=10.1093/jnci/djr243&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-cells-12-00587">
<span class="label">15.</span><cite>Drubay V., Skrypek N., Cordiez L., Vasseur R., Schulz C., Boukrout N., Duchene B., Coppin L., Van Seuningen I., Jonckheere N. TGF-betaRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727. Cancers. 2018;10:254.  doi: 10.3390/cancers10080254.</cite> [<a href="https://doi.org/10.3390/cancers10080254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6116183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30065235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=TGF-betaRII%20Knock-down%20in%20Pancreatic%20Cancer%20Cells%20Promotes%20Tumor%20Growth%20and%20Gemcitabine%20Resistance.%20Importance%20of%20STAT3%20Phosphorylation%20on%20S727&amp;author=V.%20Drubay&amp;author=N.%20Skrypek&amp;author=L.%20Cordiez&amp;author=R.%20Vasseur&amp;author=C.%20Schulz&amp;volume=10&amp;publication_year=2018&amp;pages=254&amp;pmid=30065235&amp;doi=10.3390/cancers10080254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-cells-12-00587">
<span class="label">16.</span><cite>Hsieh Y.Y., Liu T.P., Chou C.J., Chen H.Y., Lee K.H., Yang P.M. Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma. Genes. 2019;10:766.  doi: 10.3390/genes10100766.</cite> [<a href="https://doi.org/10.3390/genes10100766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6827004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31569425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes&amp;title=Integration%20of%20Bioinformatics%20Resources%20Reveals%20the%20Therapeutic%20Benefits%20of%20Gemcitabine%20and%20Cell%20Cycle%20Intervention%20in%20SMAD4-Deleted%20Pancreatic%20Ductal%20Adenocarcinoma&amp;author=Y.Y.%20Hsieh&amp;author=T.P.%20Liu&amp;author=C.J.%20Chou&amp;author=H.Y.%20Chen&amp;author=K.H.%20Lee&amp;volume=10&amp;publication_year=2019&amp;pages=766&amp;pmid=31569425&amp;doi=10.3390/genes10100766&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-cells-12-00587">
<span class="label">17.</span><cite>Westphalen C.B., Heinrich K., Böck S., Heinemann V. Molekulare Charakterisierung des Pankreaskarzinoms. Der. Onkol. 2019;25:704–709. doi: 10.1007/s00761-019-0552-y.</cite> [<a href="https://doi.org/10.1007/s00761-019-0552-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Der.%20Onkol.&amp;title=Molekulare%20Charakterisierung%20des%20Pankreaskarzinoms&amp;author=C.B.%20Westphalen&amp;author=K.%20Heinrich&amp;author=S.%20B%C3%B6ck&amp;author=V.%20Heinemann&amp;volume=25&amp;publication_year=2019&amp;pages=704-709&amp;doi=10.1007/s00761-019-0552-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-cells-12-00587">
<span class="label">18.</span><cite>Ungefroren H., Thürling I., Färber B., Kowalke T., Fischer T., De Assis L.V.M., Braun R., Castven D., Oster H., Konukiewitz B., et al.  The Quasimesenchymal Pancreatic Ductal Epithelial Cell Line PANC-1-A Useful Model to Study Clonal Heterogeneity and EMT Subtype Shifting. Cancers. 2022;14:2057.  doi: 10.3390/cancers14092057.</cite> [<a href="https://doi.org/10.3390/cancers14092057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9101310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35565186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=The%20Quasimesenchymal%20Pancreatic%20Ductal%20Epithelial%20Cell%20Line%20PANC-1-A%20Useful%20Model%20to%20Study%20Clonal%20Heterogeneity%20and%20EMT%20Subtype%20Shifting&amp;author=H.%20Ungefroren&amp;author=I.%20Th%C3%BCrling&amp;author=B.%20F%C3%A4rber&amp;author=T.%20Kowalke&amp;author=T.%20Fischer&amp;volume=14&amp;publication_year=2022&amp;pages=2057&amp;pmid=35565186&amp;doi=10.3390/cancers14092057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-cells-12-00587">
<span class="label">19.</span><cite>Witte D., Otterbein H., Forster M., Giehl K., Zeiser R., Lehnert H., Ungefroren H. Negative regulation of TGF-beta1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b. Sci. Rep. 2017;7:17313. doi: 10.1038/s41598-017-15170-6.</cite> [<a href="https://doi.org/10.1038/s41598-017-15170-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5725500/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29229918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Negative%20regulation%20of%20TGF-beta1-induced%20MKK6-p38%20and%20MEK-ERK%20signalling%20and%20epithelial-mesenchymal%20transition%20by%20Rac1b&amp;author=D.%20Witte&amp;author=H.%20Otterbein&amp;author=M.%20Forster&amp;author=K.%20Giehl&amp;author=R.%20Zeiser&amp;volume=7&amp;publication_year=2017&amp;pages=17313&amp;pmid=29229918&amp;doi=10.1038/s41598-017-15170-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-cells-12-00587">
<span class="label">20.</span><cite>Ungefroren H., Witte D., Fiedler C., Gadeken T., Kaufmann R., Lehnert H., Gieseler F., Rauch B.H. The Role of PAR2 in TGF-beta1-Induced ERK Activation and Cell Motility. Int. J. Mol. Sci. 2017;18:2776.  doi: 10.3390/ijms18122776.</cite> [<a href="https://doi.org/10.3390/ijms18122776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5751374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29261154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=The%20Role%20of%20PAR2%20in%20TGF-beta1-Induced%20ERK%20Activation%20and%20Cell%20Motility&amp;author=H.%20Ungefroren&amp;author=D.%20Witte&amp;author=C.%20Fiedler&amp;author=T.%20Gadeken&amp;author=R.%20Kaufmann&amp;volume=18&amp;publication_year=2017&amp;pages=2776&amp;pmid=29261154&amp;doi=10.3390/ijms18122776&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-cells-12-00587">
<span class="label">21.</span><cite>Chen S., Zhou Y., Chen Y., Gu J. fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884–i890. doi: 10.1093/bioinformatics/bty560.</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty560" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6129281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30423086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=fastp:%20An%20ultra-fast%20all-in-one%20FASTQ%20preprocessor&amp;author=S.%20Chen&amp;author=Y.%20Zhou&amp;author=Y.%20Chen&amp;author=J.%20Gu&amp;volume=34&amp;publication_year=2018&amp;pages=i884-i890&amp;pmid=30423086&amp;doi=10.1093/bioinformatics/bty560&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-cells-12-00587">
<span class="label">22.</span><cite>Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv. 2013 doi: 10.48550/arXiv.1303.399.1303.3997</cite> [<a href="https://doi.org/10.48550/arXiv.1303.399" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=arXiv&amp;title=Aligning%20sequence%20reads,%20clone%20sequences%20and%20assembly%20contigs%20with%20BWA-MEM&amp;author=H.%20Li&amp;publication_year=2013&amp;doi=10.48550/arXiv.1303.399&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-cells-12-00587">
<span class="label">23.</span><cite>McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., et al.  The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome. Res. 2010;20:1297–1303. doi: 10.1101/gr.107524.110.</cite> [<a href="https://doi.org/10.1101/gr.107524.110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2928508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome.%20Res.&amp;title=The%20Genome%20Analysis%20Toolkit:%20A%20MapReduce%20framework%20for%20analyzing%20next-generation%20DNA%20sequencing%20data&amp;author=A.%20McKenna&amp;author=M.%20Hanna&amp;author=E.%20Banks&amp;author=A.%20Sivachenko&amp;author=K.%20Cibulskis&amp;volume=20&amp;publication_year=2010&amp;pages=1297-1303&amp;pmid=20644199&amp;doi=10.1101/gr.107524.110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-cells-12-00587">
<span class="label">24.</span><cite>Sherry S.T., Ward M.H., Kholodov M., Baker J., Phan L., Smigielski E.M., Sirotkin K. dbSNP: The NCBI database of genetic variation. Nucleic. Acids Res. 2001;29:308–311. doi: 10.1093/nar/29.1.308.</cite> [<a href="https://doi.org/10.1093/nar/29.1.308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC29783/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11125122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic.%20Acids%20Res.&amp;title=dbSNP:%20The%20NCBI%20database%20of%20genetic%20variation&amp;author=S.T.%20Sherry&amp;author=M.H.%20Ward&amp;author=M.%20Kholodov&amp;author=J.%20Baker&amp;author=L.%20Phan&amp;volume=29&amp;publication_year=2001&amp;pages=308-311&amp;pmid=11125122&amp;doi=10.1093/nar/29.1.308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-cells-12-00587">
<span class="label">25.</span><cite>Shyr C., Tarailo-Graovac M., Gottlieb M., Lee J.J., van Karnebeek C., Wasserman W.W. FLAGS, frequently mutated genes in public exomes. BMC Med. Genom. 2014;7:64.  doi: 10.1186/s12920-014-0064-y.</cite> [<a href="https://doi.org/10.1186/s12920-014-0064-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4267152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25466818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med.%20Genom.&amp;title=FLAGS,%20frequently%20mutated%20genes%20in%20public%20exomes&amp;author=C.%20Shyr&amp;author=M.%20Tarailo-Graovac&amp;author=M.%20Gottlieb&amp;author=J.J.%20Lee&amp;author=C.%20van%20Karnebeek&amp;volume=7&amp;publication_year=2014&amp;pages=64&amp;pmid=25466818&amp;doi=10.1186/s12920-014-0064-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-cells-12-00587">
<span class="label">26.</span><cite>Boeva V., Popova T., Bleakley K., Chiche P., Cappo J., Schleiermacher G., Janoueix-Lerosey I., Delattre O., Barillot E. Control-FREEC: A tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics. 2012;28:423–425. doi: 10.1093/bioinformatics/btr670.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btr670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3268243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22155870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Control-FREEC:%20A%20tool%20for%20assessing%20copy%20number%20and%20allelic%20content%20using%20next-generation%20sequencing%20data&amp;author=V.%20Boeva&amp;author=T.%20Popova&amp;author=K.%20Bleakley&amp;author=P.%20Chiche&amp;author=J.%20Cappo&amp;volume=28&amp;publication_year=2012&amp;pages=423-425&amp;pmid=22155870&amp;doi=10.1093/bioinformatics/btr670&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-cells-12-00587">
<span class="label">27.</span><cite>Pedersen B.S., Quinlan A.R. Mosdepth: Quick coverage calculation for genomes and exomes. Bioinformatics. 2018;34:867–868. doi: 10.1093/bioinformatics/btx699.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btx699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6030888/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29096012/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Mosdepth:%20Quick%20coverage%20calculation%20for%20genomes%20and%20exomes&amp;author=B.S.%20Pedersen&amp;author=A.R.%20Quinlan&amp;volume=34&amp;publication_year=2018&amp;pages=867-868&amp;pmid=29096012&amp;doi=10.1093/bioinformatics/btx699&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-cells-12-00587">
<span class="label">28.</span><cite>Spielmann M., Kakar N., Tayebi N., Leettola C., Nurnberg G., Sowada N., Lupianez D.G., Harabula I., Flottmann R., Horn D., et al.  Exome sequencing and CRISPR/Cas genome editing identify mutations of ZAK as a cause of limb defects in humans and mice. Genome. Res. 2016;26:183–191. doi: 10.1101/gr.199430.115.</cite> [<a href="https://doi.org/10.1101/gr.199430.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4728371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26755636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome.%20Res.&amp;title=Exome%20sequencing%20and%20CRISPR/Cas%20genome%20editing%20identify%20mutations%20of%20ZAK%20as%20a%20cause%20of%20limb%20defects%20in%20humans%20and%20mice&amp;author=M.%20Spielmann&amp;author=N.%20Kakar&amp;author=N.%20Tayebi&amp;author=C.%20Leettola&amp;author=G.%20Nurnberg&amp;volume=26&amp;publication_year=2016&amp;pages=183-191&amp;pmid=26755636&amp;doi=10.1101/gr.199430.115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-cells-12-00587">
<span class="label">29.</span><cite>Dirks W.G., MacLeod R.A., Nakamura Y., Kohara A., Reid Y., Milch H., Drexler H.G., Mizusawa H. Cell line cross-contamination initiative: An interactive reference database of STR profiles covering common cancer cell lines. Int. J. Cancer. 2010;126:303–304. doi: 10.1002/ijc.24999.</cite> [<a href="https://doi.org/10.1002/ijc.24999" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19859913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Cell%20line%20cross-contamination%20initiative:%20An%20interactive%20reference%20database%20of%20STR%20profiles%20covering%20common%20cancer%20cell%20lines&amp;author=W.G.%20Dirks&amp;author=R.A.%20MacLeod&amp;author=Y.%20Nakamura&amp;author=A.%20Kohara&amp;author=Y.%20Reid&amp;volume=126&amp;publication_year=2010&amp;pages=303-304&amp;pmid=19859913&amp;doi=10.1002/ijc.24999&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-cells-12-00587">
<span class="label">30.</span><cite>Sinha A., Cherba D., Bartlam H., Lenkiewicz E., Evers L., Barrett M.T., Haab B.B. Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts. Mol. Oncol. 2014;8:1253–1265. doi: 10.1016/j.molonc.2014.04.007.</cite> [<a href="https://doi.org/10.1016/j.molonc.2014.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4198499/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24837184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Oncol.&amp;title=Mesenchymal-like%20pancreatic%20cancer%20cells%20harbor%20specific%20genomic%20alterations%20more%20frequently%20than%20their%20epithelial-like%20counterparts&amp;author=A.%20Sinha&amp;author=D.%20Cherba&amp;author=H.%20Bartlam&amp;author=E.%20Lenkiewicz&amp;author=L.%20Evers&amp;volume=8&amp;publication_year=2014&amp;pages=1253-1265&amp;pmid=24837184&amp;doi=10.1016/j.molonc.2014.04.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-cells-12-00587">
<span class="label">31.</span><cite>Schmidtlein P.M., Volz C., Braun R., Thürling I., Lapshyna O., Wellner U.F., Konukiewitz B., Lehnert H., Marquardt J.U., Ungefroren H. A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity. Cancers. 2021;13:4663.  doi: 10.3390/cancers13184663.</cite> [<a href="https://doi.org/10.3390/cancers13184663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8466512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34572891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=A%20Comparative%20Endocrine%20Trans-Differentiation%20Approach%20to%20Pancreatic%20Ductal%20Adenocarcinoma%20Cells%20with%20Different%20EMT%20Phenotypes%20Identifies%20Quasi-Mesenchymal%20Tumor%20Cells%20as%20Those%20with%20Highest%20Plasticity&amp;author=P.M.%20Schmidtlein&amp;author=C.%20Volz&amp;author=R.%20Braun&amp;author=I.%20Th%C3%BCrling&amp;author=O.%20Lapshyna&amp;volume=13&amp;publication_year=2021&amp;pages=4663&amp;pmid=34572891&amp;doi=10.3390/cancers13184663&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-cells-12-00587">
<span class="label">32.</span><cite>Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Jr., Kinzler K.W. Cancer genome landscapes. Science. 2013;339:1546–1558. doi: 10.1126/science.1235122.</cite> [<a href="https://doi.org/10.1126/science.1235122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3749880/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23539594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Cancer%20genome%20landscapes&amp;author=B.%20Vogelstein&amp;author=N.%20Papadopoulos&amp;author=V.E.%20Velculescu&amp;author=S.%20Zhou&amp;author=L.A.%20Diaz&amp;volume=339&amp;publication_year=2013&amp;pages=1546-1558&amp;pmid=23539594&amp;doi=10.1126/science.1235122&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-cells-12-00587">
<span class="label">33.</span><cite>Cancer Genome Atlas Research Network  Electronic address, a.a.d.h.e.; Cancer Genome Atlas Research, N. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32:185–203 e113. doi: 10.1016/j.ccell.2017.07.007.</cite> [<a href="https://doi.org/10.1016/j.ccell.2017.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5964983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28810144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Electronic%20address,%20a.a.d.h.e.;%20Cancer%20Genome%20Atlas%20Research,%20N.%20Integrated%20Genomic%20Characterization%20of%20Pancreatic%20Ductal%20Adenocarcinoma&amp;volume=32&amp;publication_year=2017&amp;pages=185-203%20e113&amp;pmid=28810144&amp;doi=10.1016/j.ccell.2017.07.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-cells-12-00587">
<span class="label">34.</span><cite>Kim Y.J., Hwang J.S., Hong Y.B., Bae I., Seong Y.S. Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine. Anticancer. Res. 2012;32:799–806.</cite> [<a href="/articles/PMC3508670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22399597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer.%20Res.&amp;title=Transforming%20growth%20factor%20beta%20receptor%20I%20inhibitor%20sensitizes%20drug-resistant%20pancreatic%20cancer%20cells%20to%20gemcitabine&amp;author=Y.J.%20Kim&amp;author=J.S.%20Hwang&amp;author=Y.B.%20Hong&amp;author=I.%20Bae&amp;author=Y.S.%20Seong&amp;volume=32&amp;publication_year=2012&amp;pages=799-806&amp;pmid=22399597&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-cells-12-00587">
<span class="label">35.</span><cite>Melisi D., Garcia-Carbonero R., Macarulla T., Pezet D., Deplanque G., Fuchs M., Trojan J., Oettle H., Kozloff M., Cleverly A., et al.  Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. Br. J. Cancer. 2018;119:1208–1214. doi: 10.1038/s41416-018-0246-z.</cite> [<a href="https://doi.org/10.1038/s41416-018-0246-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6251034/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30318515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Cancer&amp;title=Galunisertib%20plus%20gemcitabine%20vs.%20gemcitabine%20for%20first-line%20treatment%20of%20patients%20with%20unresectable%20pancreatic%20cancer&amp;author=D.%20Melisi&amp;author=R.%20Garcia-Carbonero&amp;author=T.%20Macarulla&amp;author=D.%20Pezet&amp;author=G.%20Deplanque&amp;volume=119&amp;publication_year=2018&amp;pages=1208-1214&amp;pmid=30318515&amp;doi=10.1038/s41416-018-0246-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-cells-12-00587">
<span class="label">36.</span><cite>Atienza J.M., Yu N., Kirstein S.L., Xi B., Wang X., Xu X., Abassi Y.A. Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev.. Technol. 2006;4:597–607. doi: 10.1089/adt.2006.4.597.</cite> [<a href="https://doi.org/10.1089/adt.2006.4.597" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17115930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Assay%20Drug%20Dev..%20Technol.&amp;title=Dynamic%20and%20label-free%20cell-based%20assays%20using%20the%20real-time%20cell%20electronic%20sensing%20system&amp;author=J.M.%20Atienza&amp;author=N.%20Yu&amp;author=S.L.%20Kirstein&amp;author=B.%20Xi&amp;author=X.%20Wang&amp;volume=4&amp;publication_year=2006&amp;pages=597-607&amp;pmid=17115930&amp;doi=10.1089/adt.2006.4.597&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-cells-12-00587">
<span class="label">37.</span><cite>Zuckerman D.S., Ryan D.P. Adjuvant therapy for pancreatic cancer: A review. Cancer. 2008;112:243–249. doi: 10.1002/cncr.23174.</cite> [<a href="https://doi.org/10.1002/cncr.23174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18050292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Adjuvant%20therapy%20for%20pancreatic%20cancer:%20A%20review&amp;author=D.S.%20Zuckerman&amp;author=D.P.%20Ryan&amp;volume=112&amp;publication_year=2008&amp;pages=243-249&amp;pmid=18050292&amp;doi=10.1002/cncr.23174&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-cells-12-00587">
<span class="label">38.</span><cite>Li D., Xie K., Wolff R., Abbruzzese J.L. Pancreatic cancer. Lancet. 2004;363:1049–1057. doi: 10.1016/S0140-6736(04)15841-8.</cite> [<a href="https://doi.org/10.1016/S0140-6736(04)15841-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15051286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Pancreatic%20cancer&amp;author=D.%20Li&amp;author=K.%20Xie&amp;author=R.%20Wolff&amp;author=J.L.%20Abbruzzese&amp;volume=363&amp;publication_year=2004&amp;pages=1049-1057&amp;pmid=15051286&amp;doi=10.1016/S0140-6736(04)15841-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-cells-12-00587">
<span class="label">39.</span><cite>Strobel O., Neoptolemos J., Jager D., Buchler M.W. Optimizing the outcomes of pancreatic cancer surgery. Nat. Rev. Clin. Oncol. 2019;16:11–26. doi: 10.1038/s41571-018-0112-1.</cite> [<a href="https://doi.org/10.1038/s41571-018-0112-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30341417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;title=Optimizing%20the%20outcomes%20of%20pancreatic%20cancer%20surgery&amp;author=O.%20Strobel&amp;author=J.%20Neoptolemos&amp;author=D.%20Jager&amp;author=M.W.%20Buchler&amp;volume=16&amp;publication_year=2019&amp;pages=11-26&amp;pmid=30341417&amp;doi=10.1038/s41571-018-0112-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-cells-12-00587">
<span class="label">40.</span><cite>Ciliberto D., Staropoli N., Chiellino S., Botta C., Tassone P., Tagliaferri P. Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer. Pancreatology. 2016;16:249–258. doi: 10.1016/j.pan.2016.01.003.</cite> [<a href="https://doi.org/10.1016/j.pan.2016.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26852170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pancreatology&amp;title=Systematic%20review%20and%20meta-analysis%20on%20targeted%20therapy%20in%20advanced%20pancreatic%20cancer&amp;author=D.%20Ciliberto&amp;author=N.%20Staropoli&amp;author=S.%20Chiellino&amp;author=C.%20Botta&amp;author=P.%20Tassone&amp;volume=16&amp;publication_year=2016&amp;pages=249-258&amp;pmid=26852170&amp;doi=10.1016/j.pan.2016.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-cells-12-00587">
<span class="label">41.</span><cite>Birnbaum D.J., Finetti P., Birnbaum D., Mamessier E., Bertucci F. Validation and comparison of the molecular classifications of pancreatic carcinomas. Mol. Cancer. 2017;16:168. doi: 10.1186/s12943-017-0739-z.</cite> [<a href="https://doi.org/10.1186/s12943-017-0739-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5674743/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29110659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cancer&amp;title=Validation%20and%20comparison%20of%20the%20molecular%20classifications%20of%20pancreatic%20carcinomas&amp;author=D.J.%20Birnbaum&amp;author=P.%20Finetti&amp;author=D.%20Birnbaum&amp;author=E.%20Mamessier&amp;author=F.%20Bertucci&amp;volume=16&amp;publication_year=2017&amp;pages=168&amp;pmid=29110659&amp;doi=10.1186/s12943-017-0739-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-cells-12-00587">
<span class="label">42.</span><cite>Kalimuthu S.N., Wilson G.W., Grant R.C., Seto M., O’Kane G., Vajpeyi R., Notta F., Gallinger S., Chetty R. Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome. Gut. 2020;69:317–328. doi: 10.1136/gutjnl-2019-318217.</cite> [<a href="https://doi.org/10.1136/gutjnl-2019-318217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31201285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Morphological%20classification%20of%20pancreatic%20ductal%20adenocarcinoma%20that%20predicts%20molecular%20subtypes%20and%20correlates%20with%20clinical%20outcome&amp;author=S.N.%20Kalimuthu&amp;author=G.W.%20Wilson&amp;author=R.C.%20Grant&amp;author=M.%20Seto&amp;author=G.%20O%E2%80%99Kane&amp;volume=69&amp;publication_year=2020&amp;pages=317-328&amp;pmid=31201285&amp;doi=10.1136/gutjnl-2019-318217&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-cells-12-00587">
<span class="label">43.</span><cite>Richter M., Piwocka O., Musielak M., Piotrowski I., Suchorska W.M., Trzeciak T. From Donor to the Lab: AFascinating Journey of Primary Cell Lines. Front. Cell Dev. Biol. 2021;9:711381. doi: 10.3389/fcell.2021.711381.</cite> [<a href="https://doi.org/10.3389/fcell.2021.711381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8356673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34395440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell%20Dev.%20Biol.&amp;title=From%20Donor%20to%20the%20Lab:%20AFascinating%20Journey%20of%20Primary%20Cell%20Lines&amp;author=M.%20Richter&amp;author=O.%20Piwocka&amp;author=M.%20Musielak&amp;author=I.%20Piotrowski&amp;author=W.M.%20Suchorska&amp;volume=9&amp;publication_year=2021&amp;pages=711381&amp;pmid=34395440&amp;doi=10.3389/fcell.2021.711381&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-cells-12-00587">
<span class="label">44.</span><cite>Braun R., Anthuber L., Hirsch D., Wangsa D., Lack J., McNeil N.E., Heselmeyer-Haddad K., Torres I., Wangsa D., Brown M.A., et al.  Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response. Clin. Cancer Res. 2020;26:3468–3480. doi: 10.1158/1078-0432.CCR-19-1984.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-19-1984" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8496519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32253233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=Single-Cell-Derived%20Primary%20Rectal%20Carcinoma%20Cell%20Lines%20Reflect%20Intratumor%20Heterogeneity%20Associated%20with%20Treatment%20Response&amp;author=R.%20Braun&amp;author=L.%20Anthuber&amp;author=D.%20Hirsch&amp;author=D.%20Wangsa&amp;author=J.%20Lack&amp;volume=26&amp;publication_year=2020&amp;pages=3468-3480&amp;pmid=32253233&amp;doi=10.1158/1078-0432.CCR-19-1984&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-cells-12-00587">
<span class="label">45.</span><cite>Sinha D., Saha P., Samanta A., Bishayee A. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression. Biomolecules. 2020;10:1561.  doi: 10.3390/biom10111561.</cite> [<a href="https://doi.org/10.3390/biom10111561" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7697085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33207810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=Emerging%20Concepts%20of%20Hybrid%20Epithelial-to-Mesenchymal%20Transition%20in%20Cancer%20Progression&amp;author=D.%20Sinha&amp;author=P.%20Saha&amp;author=A.%20Samanta&amp;author=A.%20Bishayee&amp;volume=10&amp;publication_year=2020&amp;pages=1561&amp;pmid=33207810&amp;doi=10.3390/biom10111561&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-cells-12-00587">
<span class="label">46.</span><cite>Schniewind B., Groth S., Sebens Müerköster S., Sipos B., Schäfer H., Kalthoff H., Fändrich F., Ungefroren H. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Oncogene. 2007;26:4850–4862. doi: 10.1038/sj.onc.1210272.</cite> [<a href="https://doi.org/10.1038/sj.onc.1210272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17297450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Dissecting%20the%20role%20of%20TGF-beta%20type%20I%20receptor/ALK5%20in%20pancreatic%20ductal%20adenocarcinoma:%20Smad%20activation%20is%20crucial%20for%20both%20the%20tumor%20suppressive%20and%20prometastatic%20function&amp;author=B.%20Schniewind&amp;author=S.%20Groth&amp;author=S.%20Sebens%20M%C3%BCerk%C3%B6ster&amp;author=B.%20Sipos&amp;author=H.%20Sch%C3%A4fer&amp;volume=26&amp;publication_year=2007&amp;pages=4850-4862&amp;pmid=17297450&amp;doi=10.1038/sj.onc.1210272&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-cells-12-00587">
<span class="label">47.</span><cite>Schmidtlein P.M., Volz C., Hackel A., Thürling I., Castven D., Braun R., Wellner U.F., Konukiewitz B., Riemekasten G., Lehnert H., et al.  Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors. Cancers. 2021;13:5541.  doi: 10.3390/cancers13215541.</cite> [<a href="https://doi.org/10.3390/cancers13215541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8583136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34771704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Activation%20of%20a%20Ductal-to-Endocrine%20Transdifferentiation%20Transcriptional%20Program%20in%20the%20Pancreatic%20Cancer%20Cell%20Line%20PANC-1%20Is%20Controlled%20by%20RAC1%20and%20RAC1b%20through%20Antagonistic%20Regulation%20of%20Stemness%20Factors&amp;author=P.M.%20Schmidtlein&amp;author=C.%20Volz&amp;author=A.%20Hackel&amp;author=I.%20Th%C3%BCrling&amp;author=D.%20Castven&amp;volume=13&amp;publication_year=2021&amp;pages=5541&amp;pmid=34771704&amp;doi=10.3390/cancers13215541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-cells-12-00587">
<span class="label">48.</span><cite>Schniewind B., Christgen M., Kurdow R., Haye S., Kremer B., Kalthoff H., Ungefroren H. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Int. J. Cancer. 2004;109:182–188. doi: 10.1002/ijc.11679.</cite> [<a href="https://doi.org/10.1002/ijc.11679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14750167/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Resistance%20of%20pancreatic%20cancer%20to%20gemcitabine%20treatment%20is%20dependent%20on%20mitochondria-mediated%20apoptosis&amp;author=B.%20Schniewind&amp;author=M.%20Christgen&amp;author=R.%20Kurdow&amp;author=S.%20Haye&amp;author=B.%20Kremer&amp;volume=109&amp;publication_year=2004&amp;pages=182-188&amp;pmid=14750167&amp;doi=10.1002/ijc.11679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49-cells-12-00587">
<span class="label">49.</span><cite>Shi X., Liu S., Kleeff J., Friess H., Büchler M.W. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology. 2002;62:354–362. doi: 10.1159/000065068.</cite> [<a href="https://doi.org/10.1159/000065068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12138244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology&amp;title=Acquired%20resistance%20of%20pancreatic%20cancer%20cells%20towards%205-Fluorouracil%20and%20gemcitabine%20is%20associated%20with%20altered%20expression%20of%20apoptosis-regulating%20genes&amp;author=X.%20Shi&amp;author=S.%20Liu&amp;author=J.%20Kleeff&amp;author=H.%20Friess&amp;author=M.W.%20B%C3%BCchler&amp;volume=62&amp;publication_year=2002&amp;pages=354-362&amp;pmid=12138244&amp;doi=10.1159/000065068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50-cells-12-00587">
<span class="label">50.</span><cite>Duxbury M.S., Ito H., Zinner M.J., Ashley S.W., Whang E.E. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 2004;10:2307–2318. doi: 10.1158/1078-0432.CCR-1183-3.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-1183-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15073106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=Inhibition%20of%20SRC%20tyrosine%20kinase%20impairs%20inherent%20and%20acquired%20gemcitabine%20resistance%20in%20human%20pancreatic%20adenocarcinoma%20cells&amp;author=M.S.%20Duxbury&amp;author=H.%20Ito&amp;author=M.J.%20Zinner&amp;author=S.W.%20Ashley&amp;author=E.E.%20Whang&amp;volume=10&amp;publication_year=2004&amp;pages=2307-2318&amp;pmid=15073106&amp;doi=10.1158/1078-0432.CCR-1183-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51-cells-12-00587">
<span class="label">51.</span><cite>Giovannetti E., Mey V., Danesi R., Mosca I., Del Tacca M. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines. Clin. Cancer Res. 2004;10:2936–2943. doi: 10.1158/1078-0432.CCR-03-0520.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-03-0520" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15131028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=Synergistic%20cytotoxicity%20and%20pharmacogenetics%20of%20gemcitabine%20and%20pemetrexed%20combination%20in%20pancreatic%20cancer%20cell%20lines&amp;author=E.%20Giovannetti&amp;author=V.%20Mey&amp;author=R.%20Danesi&amp;author=I.%20Mosca&amp;author=M.%20Del%20Tacca&amp;volume=10&amp;publication_year=2004&amp;pages=2936-2943&amp;pmid=15131028&amp;doi=10.1158/1078-0432.CCR-03-0520&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52-cells-12-00587">
<span class="label">52.</span><cite>Mori R., Ishikawa T., Ichikawa Y., Taniguchi K., Matsuyama R., Ueda M., Fujii Y., Endo I., Togo S., Danenberg P.V., et al.  Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells. Oncol. Rep. 2007;17:1201–1205. doi: 10.3892/or.17.5.1201.</cite> [<a href="https://doi.org/10.3892/or.17.5.1201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17390066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Rep.&amp;title=Human%20equilibrative%20nucleoside%20transporter%201%20is%20associated%20with%20the%20chemosensitivity%20of%20gemcitabine%20in%20human%20pancreatic%20adenocarcinoma%20and%20biliary%20tract%20carcinoma%20cells&amp;author=R.%20Mori&amp;author=T.%20Ishikawa&amp;author=Y.%20Ichikawa&amp;author=K.%20Taniguchi&amp;author=R.%20Matsuyama&amp;volume=17&amp;publication_year=2007&amp;pages=1201-1205&amp;pmid=17390066&amp;doi=10.3892/or.17.5.1201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53-cells-12-00587">
<span class="label">53.</span><cite>Begg S.K.S., Birnbaum D.J., Clark J.W., Mino-Kenudson M., Wellner U.F., Schilling O., Lillemoe K.D., Warshaw A.L., Castillo C.F., Liss A.S. FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines. Anticancer. Res. 2020;40:3659–3667. doi: 10.21873/anticanres.14355.</cite> [<a href="https://doi.org/10.21873/anticanres.14355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32620605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer.%20Res.&amp;title=FOLFIRINOX%20Versus%20Gemcitabine-based%20Therapy%20for%20Pancreatic%20Ductal%20Adenocarcinoma:%20Lessons%20from%20Patient-derived%20Cell%20Lines&amp;author=S.K.S.%20Begg&amp;author=D.J.%20Birnbaum&amp;author=J.W.%20Clark&amp;author=M.%20Mino-Kenudson&amp;author=U.F.%20Wellner&amp;volume=40&amp;publication_year=2020&amp;pages=3659-3667&amp;pmid=32620605&amp;doi=10.21873/anticanres.14355&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54-cells-12-00587">
<span class="label">54.</span><cite>Hass R., von der Ohe J., Ungefroren H. The Intimate Relationship Among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes. Cancers. 2020;12:3674.  doi: 10.3390/cancers12123674.</cite> [<a href="https://doi.org/10.3390/cancers12123674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7762343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33297508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=The%20Intimate%20Relationship%20Among%20EMT,%20MET%20and%20TME:%20A%20T(ransdifferentiation)%20E(nhancing)%20M(ix)%20to%20Be%20Exploited%20for%20Therapeutic%20Purposes&amp;author=R.%20Hass&amp;author=J.%20von%20der%20Ohe&amp;author=H.%20Ungefroren&amp;volume=12&amp;publication_year=2020&amp;pages=3674&amp;pmid=33297508&amp;doi=10.3390/cancers12123674&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55-cells-12-00587">
<span class="label">55.</span><cite>Yu K.H., Ricigliano M., McCarthy B., Chou J.F., Capanu M., Cooper B., Bartlett A., Covington C., Lowery M.A., O’Reilly E.M. Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma. Cancers. 2018;10:467.  doi: 10.3390/cancers10120467.</cite> [<a href="https://doi.org/10.3390/cancers10120467" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6315371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30477242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Circulating%20Tumor%20and%20Invasive%20Cell%20Gene%20Expression%20Profile%20Predicts%20Treatment%20Response%20and%20Survival%20in%20Pancreatic%20Adenocarcinoma&amp;author=K.H.%20Yu&amp;author=M.%20Ricigliano&amp;author=B.%20McCarthy&amp;author=J.F.%20Chou&amp;author=M.%20Capanu&amp;volume=10&amp;publication_year=2018&amp;pages=467&amp;pmid=30477242&amp;doi=10.3390/cancers10120467&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56-cells-12-00587">
<span class="label">56.</span><cite>Shin S.H., Kim S.C., Hong S.M., Kim Y.H., Song K.B., Park K.M., Lee Y.J. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival. Pancreas. 2013;42:216–222. doi: 10.1097/MPA.0b013e31825b6ab0.</cite> [<a href="https://doi.org/10.1097/MPA.0b013e31825b6ab0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23344532/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pancreas&amp;title=Genetic%20alterations%20of%20K-ras,%20p53,%20c-erbB-2,%20and%20DPC4%20in%20pancreatic%20ductal%20adenocarcinoma%20and%20their%20correlation%20with%20patient%20survival&amp;author=S.H.%20Shin&amp;author=S.C.%20Kim&amp;author=S.M.%20Hong&amp;author=Y.H.%20Kim&amp;author=K.B.%20Song&amp;volume=42&amp;publication_year=2013&amp;pages=216-222&amp;pmid=23344532&amp;doi=10.1097/MPA.0b013e31825b6ab0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57-cells-12-00587">
<span class="label">57.</span><cite>Hsieh H.H.S., Agarwal S., Cholok D.J., Loder S.J., Kaneko K., Huber A., Chung M.T., Ranganathan K., Habbouche J., Li J., et al.  Coordinating Tissue Regeneration Through Transforming Growth Factor-beta Activated Kinase 1 Inactivation and Reactivation. Stem Cells. 2019;37:766–778. doi: 10.1002/stem.2991.</cite> [<a href="https://doi.org/10.1002/stem.2991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6542699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30786091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cells&amp;title=Coordinating%20Tissue%20Regeneration%20Through%20Transforming%20Growth%20Factor-beta%20Activated%20Kinase%201%20Inactivation%20and%20Reactivation&amp;author=H.H.S.%20Hsieh&amp;author=S.%20Agarwal&amp;author=D.J.%20Cholok&amp;author=S.J.%20Loder&amp;author=K.%20Kaneko&amp;volume=37&amp;publication_year=2019&amp;pages=766-778&amp;pmid=30786091&amp;doi=10.1002/stem.2991&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58-cells-12-00587">
<span class="label">58.</span><cite>Cui Y., Brosnan J.A., Blackford A.L., Sur S., Hruban R.H., Kinzler K.W., Vogelstein B., Maitra A., Diaz L.A., Jr., Iacobuzio-Donahue C.A., et al.  Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity. Clin. Cancer Res. 2012;18:6519–6530. doi: 10.1158/1078-0432.CCR-12-0827.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-12-0827" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3513499/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22753594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=Genetically%20defined%20subsets%20of%20human%20pancreatic%20cancer%20show%20unique%20in%20vitro%20chemosensitivity&amp;author=Y.%20Cui&amp;author=J.A.%20Brosnan&amp;author=A.L.%20Blackford&amp;author=S.%20Sur&amp;author=R.H.%20Hruban&amp;volume=18&amp;publication_year=2012&amp;pages=6519-6530&amp;pmid=22753594&amp;doi=10.1158/1078-0432.CCR-12-0827&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59-cells-12-00587">
<span class="label">59.</span><cite>Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., et al.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–607. doi: 10.1038/nature11003.</cite> [<a href="https://doi.org/10.1038/nature11003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3320027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22460905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20Cancer%20Cell%20Line%20Encyclopedia%20enables%20predictive%20modelling%20of%20anticancer%20drug%20sensitivity&amp;author=J.%20Barretina&amp;author=G.%20Caponigro&amp;author=N.%20Stransky&amp;author=K.%20Venkatesan&amp;author=A.A.%20Margolin&amp;volume=483&amp;publication_year=2012&amp;pages=603-607&amp;pmid=22460905&amp;doi=10.1038/nature11003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60-cells-12-00587">
<span class="label">60.</span><cite>Cancer Cell Line Encyclopedia C., Genomics of Drug Sensitivity in Cancer C. Pharmacogenomic agreement between two cancer cell line data sets. Nature. 2015;528:84–87. doi: 10.1038/nature15736.</cite> [<a href="https://doi.org/10.1038/nature15736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6343827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26570998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Pharmacogenomic%20agreement%20between%20two%20cancer%20cell%20line%20data%20sets&amp;author=C.%20Cancer%20Cell%20Line%20Encyclopedia&amp;author=C.%20Genomics%20of%20Drug%20Sensitivity%20in%20Cancer&amp;volume=528&amp;publication_year=2015&amp;pages=84-87&amp;pmid=26570998&amp;doi=10.1038/nature15736&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61-cells-12-00587">
<span class="label">61.</span><cite>Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment. Clin. Cancer Res. 2012;18:4266–4276. doi: 10.1158/1078-0432.CCR-11-3114.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-11-3114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3442232/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22896693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=The%20pancreas%20cancer%20microenvironment&amp;author=C.%20Feig&amp;author=A.%20Gopinathan&amp;author=A.%20Neesse&amp;author=D.S.%20Chan&amp;author=N.%20Cook&amp;volume=18&amp;publication_year=2012&amp;pages=4266-4276&amp;pmid=22896693&amp;doi=10.1158/1078-0432.CCR-11-3114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62-cells-12-00587">
<span class="label">62.</span><cite>Jiang X., Seo Y.D., Chang J.H., Coveler A., Nigjeh E.N., Pan S., Jalikis F., Yeung R.S., Crispe I.N., Pillarisetty V.G. Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment. Oncoimmunology. 2017;6:e1333210. doi: 10.1080/2162402X.2017.1333210.</cite> [<a href="https://doi.org/10.1080/2162402X.2017.1333210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5543820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28811976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncoimmunology&amp;title=Long-lived%20pancreatic%20ductal%20adenocarcinoma%20slice%20cultures%20enable%20precise%20study%20of%20the%20immune%20microenvironment&amp;author=X.%20Jiang&amp;author=Y.D.%20Seo&amp;author=J.H.%20Chang&amp;author=A.%20Coveler&amp;author=E.N.%20Nigjeh&amp;volume=6&amp;publication_year=2017&amp;pages=e1333210&amp;pmid=28811976&amp;doi=10.1080/2162402X.2017.1333210&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63-cells-12-00587">
<span class="label">63.</span><cite>Hessmann E., Patzak M.S., Klein L., Chen N., Kari V., Ramu I., Bapiro T.E., Frese K.K., Gopinathan A., Richards F.M., et al.  Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer. Gut. 2018;67:497–507. doi: 10.1136/gutjnl-2016-311954.</cite> [<a href="https://doi.org/10.1136/gutjnl-2016-311954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5868285/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28077438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Fibroblast%20drug%20scavenging%20increases%20intratumoural%20gemcitabine%20accumulation%20in%20murine%20pancreas%20cancer&amp;author=E.%20Hessmann&amp;author=M.S.%20Patzak&amp;author=L.%20Klein&amp;author=N.%20Chen&amp;author=V.%20Kari&amp;volume=67&amp;publication_year=2018&amp;pages=497-507&amp;pmid=28077438&amp;doi=10.1136/gutjnl-2016-311954&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9954561/bin/cells-12-00587-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (1.7MB, zip) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data reported are contained in the “Results” section and the <a href="#app1-cells-12-00587" class="usa-link">supplementary material</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cells are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/cells12040587"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/cells-12-00587.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9954561/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9954561/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9954561%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954561/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9954561/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9954561/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/36831254/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9954561/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/36831254/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9954561/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9954561/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="b6cR8OWEhBuf2RFom9RRk9Og4mUZgxfoNgC4UGpcyjYzdXapC8frRhHWbejcjiKT">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
